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ABSTRACT
Bowman's capsule parie ta l ep ithe lia l cell activation occurs in  several 
hum an pro life ra tive  glom erulonephritides. The ce llu lar com position o f the 
resulting crescentic lesions is controversial, although a popula tion o f renal 
progenitor cells, w h ich in  adu lt healthy k idney contributes to the 
physiological cell turnover, has been proposed to be a m ajor constituent. 
In  th is study we try  to get lig h t in to  the m ediators invo lved in  the aberrant 
progenitor cell p ro life ra tion  and m igra tion  in to  the Bowman's space, 
w h ich occurs in  presence o f an extended glom erular in ju ry .
To th is aim , we studied 36 renal biopsies o f patients w ith  p ro life ra tive  and 
non pro life ra tive  glom erulopathies. In  paralle l, we also analyzed the 
M unich W istar From ter rats w ith  p ro life ra tive  glom erulonephritis, 
characterizing fo r the firs t tim e a popula tion o f renal progenitor cells also 
in  rodents. We demonstrated tha t dysregulated progenitor cells o f the 
Bowman's capsule invade the glom erular tu ft exclusively in  p ro life ra tive  
disorders. In  both humans and rats, up-regulation o f the CXCR4 
chemokine receptor on progenitor cells was accompanied by h igh 
expression o f its  ligand, strom al-derived factor-1 (SDF-1) in  podocytes. 
Parietal ep ithe lia l cell p ro life ra tion  m igh t be sustained by increased 
expression o f the ang iotensin ll ty p e l (A T i) receptor. Treatment w ith  the 
antihypertensive drug angiotensin-converting enzyme (ACE) in h ib ito r, 
reduces the num ber and the extension o f crescents, lim itin g  progenitor cell 
p ro life ra tion  and m igration. M oreover, ACE in h ib ito r norm alized the 
expression o f CXCR4, SDF-1 and A T i receptor on progenitor cells.
These results suggest tha t glom erular crescents derive from  the 
p ro life ra tion  and m igra tion  o f renal progenitors in  response to in jured 
podocytes. The SDF-1/CXCR4 axis, together w ith  the A n g ll/A T i receptor 
pathway, contributes to the dysregulated response of renal progenitors. 
Targeting the A n g ll/A T i/C X C R 4  pathw ay m ay be beneficial in  severe 
form s o f glom erular p ro life ra tive  disorders.
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INTRODUCTION
CHAPTER 1: INTRODUCTION
1.1 C hronic k id ney disease
Chronic kidney disease (CKD) is a general term  to indicate the slow 
loss o f kidney function  over tim e, and also includes some com plications 
such as hypertension, anemia, m a lnu trition , bone and m inera l disorders, 
and neuropathy as w e ll as increased risk  o f cardiovascular disease 
(Dinneen et ah, 1997). The de fin ition  o f CKD is based on the presence of 
k idney damage (i.e. a lbum inuria) or decreased kidney function  (i.e. 
glom erular filtra tio n  rate [GFR] below  60 m l/m in  per 1.73 m 2) over a 
period o f 3 months.
CKD is. a w o rldw ide  threat to pub lic health since it  has been 
estimated tha t diseases of the kidney account fo r 830,000 deaths every 
year, w ith  the sharp rise o f renal replacement therapy now  exceeding tw o 
m illio n  patients fo r cost o f m ore than a tr illio n  US$ (Just et al., 2008). The 
burden o f CKD is no t lim ite d  to the demand fo r renal replacement 
therapies (RRT), w h ich consists p rim a rily  o f k idney transplantation, 
haem odialysis and peritoneal dialysis, since they are also a m ajor 
determ inant o f cardiovascular diseases w ith  a d irect im pact on health 
(G ride lli et al., 2000; Van Der Meer et al, 2010).
A pproxim ate ly 2 m illio n  people are curren tly treated w ith  RRT, b u t 
th is lik e ly  represents less than 10% of those w ho need them  (Eggers et ah, 
2011). M ore than 90% of these ind iv idua ls live  in  industria lized  countries, 
w h ile  available RRT in  developing countries is scarce, and n u ll in  
underdeveloped areas. M any developed nations spend more than 2-3% o f
2
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the ir annual health-care budget to provide treatm ent fo r end-stage renal 
disease (ESRD), w h ile  the popu la tion  w ith  ESRD represents 
approxim ately 0.02-0.03% o f the to ta l popu la tion  (Couser et al., 2011).
The leading causes o f CKD leading to k idney fa ilu re  in  the U n ited 
States are diabetes, hypertension and glom erulonephritis (C ollins et al., 
2009). The kidney disease tends to worsen over tim e through a sequence 
of risk  factors (i.e. genetic, developm ental or dem ographic), conditions 
that can cause kidney damage (i.e. diabetes, hypertension and 
autoim m une diseases), and progression factors (i.e. elevated b lood 
pressure and pro te inuria , and sm oking). Once established, CKD 
progression is influenced by a num ber o f non-m odifiable and m odifiab le  
risk  factors (Taal et al., 2008). The non-m odifiable progression risk  factors 
include age, race and genetics, w h ile  the m odifiable progression risk  
factors include systemic hypertension, p ro te inuria  and m etabolic factors. 
M oreover, cigarette sm oking, alcohol consum ption and d rug  use can 
influence the progression o f CKD (Floege J et al., 2010).
The progression o f CKD towards ESRD is characterized by the 
progressive loss o f renal cells through apoptosis or necrosis, and the ir 
replacement w ith  scars, fib ro tic  tissue made o f collagenous extracellu lar 
m atrix (ECM). Scarring, that leads to loss o f kidney function, m ay affect 
d iffe ren t renal d istricts such as the g lom eru li (glom erulosclerosis), tubules 
and in te rs titium  (tubu lo in te rs titia l fibrosis), and vessels (vascular 
sclerosis) (Floege J et al., 2010).
Renal outcomes are m ostly unfavorable in  patients w ith  progressive
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kidney disease, show ing the kidney's lim ite d  capacity to repair chronic 
damage. However, experim ental and c lin ica l evidence indicates tha t there 
are drugs able to reduce risk  of progression to ESRD, o ffe ring new hope 
fo r the fu tu re  o f kidney regeneration. In  add ition , lifesty le  in tervention 
(i.e. w e igh t loss or sm oking cessation), tig h t diabetes control, and 
treatm ent o f other cardiovascular risk  factors as dyslip idem ia are 
associated w ith  a slow  progression to ESRD (Couser et ah, 2011).
1.2 The M W F ra t m odel
In  the past years, i t  has been suggested that a reduced num ber of 
nephrons m ay predispose to systemic hypertension and glom erular in ju ry . 
A  consequence o f a lo w  num ber o f nephrons is a reduced a b ility  to secrete 
sodium. Compensatory hem odynam ic changes may develop to 
compensate th is renal abnorm ality and m ay predispose to progressive 
glom erular functiona l and structura l deterioriation. Because o f the 
lim ita tions in  estim ating the num ber o f nephrons in  the liv in g  hum an 
kidney, the paralle lism  between the nephron num ber and the 
hem odynam ic changes has been studied fo r the firs t tim e in  the M unich 
W istar From ter (MW F) ra t m odel (Fassi et ah, 1998). These animals have 
been selected from  the M unich-W istar stra in by From ter fo r having a h igh 
num ber o f superficia l g lom eru li (Hackbart et ah, 1980; Hackbart et ah, 
1983). Male MW F rats had body and kidney weights low er than contro l
4
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W istar animals o f the same age. This could possibly be a ttributab le  to a 
grow th  defect, lik e ly  related to the defect in  grow th horm one secretion 
(M artin  et at, 1974) o f the M unich-W istar stra in  from  w h ich  the studied 
stra in orig inated (Fassi et al., 1998). The genetic defect in  g row th  horm one 
m ay lead to im paired nephrogenesis, resu lting in  reduced nephron 
num ber, about 50% in  average, and in  superficia l cap illa ry tu fts  no t 
covered by the periphera l layer o f proxim al tubules tha t is norm a lly  
form ed du ring  the last phase o f nephrogenesis (Fassi et al., 1998; M acconi 
et al., 2006).
The MW F rats w ith  a h igh num ber o f superfic ia l nephrons, show an 
elevated u rina ry  pro te in  excretion and a h igh  systolic b lood pressure. To 
investigate the possible corre lation between the num ber o f superfic ia l 
g lom eru li and these pathological changes, MW F rats have been crossed 
and backcrossed to W istar animals w ith  no superficia l nephrons in  order 
to  produce genotypes w ith  d iffe ren t numbers o f superficia l g lom eru li. The 
analysis of the 12 available genotypes has demonstrated a positive 
corre lation between the am ount o f superficia l g lom eru li, u rin a ry  p ro te in  
excretion and systolic blood pressure levels (Flackbarth et al., 1991). A bou t 
50% o f the u rina ry  pro te in  consisted o f album in, whereas 35% was a sex- 
dependent lo w  m olecular w e igh t protein. A lbum in  excretion levels 
increase w ith  age in  male MW F rats, whereas excretion o f the sex- 
dependent p ro te in  decreases (Remuzzi A . et al., 1992).
The progressive nephropathy w h ich characterizes the M W F ra t 
m odel is sex-dependent. S tarting from  few  weeks o f life , u rin a ry  p ro te in
5
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excretion in  male rats is already sign ifican tly h igher than in  females, in  
w h ich p ro te inuria  level is w ith in  the norm al range. By com paring animals 
o f the same age, male MW F rats also show a higher glom erular 
u ltra filtra tio n  coefficient, tha t is the product o f hydrau lic perm eability and 
the filte rin g  surface area o f glom erular membrane, than in  female MW F 
rats (Remuzzi A . et al., 1988).
Studies conducted com paring the effects o f the angiotensin- 
converting enzyme (ACE) in h ib ito r lis in o p ril w ith  those o f a specific 
angiotensin receptor antagonist (ZD7155) on the renal function in  male 
MW F rats demonstrated tha t angiotensin I I  is the lik e ly  m ediator o f 
pro te inuria  and glomerulosclerosis w h ich develop spontaneously w ith  
age in  th is m odel (Remuzzi A . et al., 1996). ACE inh ib ito rs protect 
glom erular m icrocircu lation and prevent progressive renal in ju ry  in  this 
stra in by a mechanism tha t is no t d irectly  related to the ir antihypertensive 
action. Indeed, by com paring the ACE in h ib ito r lis in o p ril w ith  those o f 
another antihypertensive drug, the calcium  channel blocker n itrend ip ine, 
a study conducted in  our Institu te  has demonstrated tha t n itrend ip ine, 
despite s im ila r blood pressure control, was ineffective in  preventing both 
pro te inuria  and glomerulosclerosis (Remuzzi A. et al., 1994).
1.3 E xtracap illa ry g lom eru lonephritis
C e llu lar crescents, defined as m ultilayered accum ulation o f cells in  
the glom erular Bowman's space, are feature o f d iffe ren t kinds o f
6
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glom erulonephritides w hich, if  le ft untreated, can resu lt in  ra p id ly  
progressive renal fa ilu re  (Singh KS et a l, 2011). The m ost ha rm fu l and 
d iffuse crescentic lesions are found in  kidneys o f patients w ith  
in flam m atory glom erular diseases, typ ica lly  crescentic 
g lom erulonephritis, b u t also other p ro life ra tive  form s in c lud ing  lupus 
nephritis, IgA  nephropathy, and m em branoproliferative 
glom erulonephritis (Kambham et a l, 2012; Jennette et a l, 2003).
The cellu lar components o f glom erular crescents have been 
extensively studied, w ith  controversial find ings as to the ir possible 
pathogenetic role. Early studies in  im m une glom eru lonephritis revealed 
the contribu tion  o f macrophages w hich, by releasing pro in flam m atory 
cytokines, could prom ote self-recruitm ent and p ro life ra tion  o f g lom erular 
cells (C atte ll et al, 1978, Jennette et a l, 1986).
Subsequent studies a ttribu ted  to Bowman's capsule in te g rity  a key 
role in  determ ining the nature o f crescent cells. By exam ining ce llu la r 
crescents in  d iffe ren t cases o f hum an crescentic g lom eru lonephritis, 
Boucher and coworkers found tha t parie ta l ep ithe lia l cells (PECs) 
represent the m ajor ce ll popu la tion  w ith in  crescents w ith  in tact Bowm an's 
capsule (Boucher et a l, 1987). The same observations have been done in  
the la ter tim e in  various anim al models (Lan et a l, 1992; 
Ophashcharoensuk et a l, 1998; Le H ir et al., 2001).
D iffe ren t studies also suggested the podocyte con tribu tion  to  the 
crescent. By using a genetic cell lineage-m apping approach in  an 
experim ental m odel o f crescentic g lom erulonephritis, M oeller and
7
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coworkers demonstrated that podocytes actively contribute to crescent 
form ation through p ro life ra tion  in situ. However, im m unohistochem istry 
experiments fa iled  to detect podocyte-specific proteins, in c lud ing  WT-1, 
synaptopodin and nephrin, w ith in  the area o f crescentic lesions in  mouse 
kidneys w ith  crescentic glom erulonephritis. The absence podocyte 
markers was attributed to a profound phenotypic change o f podocytes in  
tha t nephritis m odel (M oeller et al., 2004). Subsequent studies have 
confirm ed the podocyte involvem ent in  crescent fo rm ation  both in  
humans and in  animals (Bariety et al., 2005, Thorner et al., 2008). This 
theory is supported also by the study by D ing and coworkers, w hich 
demonstrated tha t in  mice, the deletion of the product o f the von H ippe l- 
L indau gene (Vhlh, encoding VH L) selectively from  podocytes causes the 
form ation o f crescentic lesions. A lthough in  crescentic glom erulonephritis, 
V H L  has no t been d irectly  im plicated in  the disease, d iffe ren t V H L 
downstream  genes are know n to be increased in  respect to controls. In  that 
study, loss o f Vhlh perm its te rm ina lly  d ifferentiated podocytes to reenter 
the cell cycle, suggesting tha t Vhlh is required by podocytes to m aintain 
glom erular in te g rity  (D ing et al., 2006).
In  the last years, d iffe ren t populations o f progenitor cells w ith  stem 
cell characteristics have been iden tified  in  d iffe ren t portions of the norm al 
a du lt kidney. Am ong them, CD24+CD133+ renal progenitor cells norm ally 
resid ing in  the inner surface o f the hum an Bowman's capsule have been 
studied, suggesting the ir a b ility  to d ifferentiate in to  podocytes in  order to 
replace the in ju red  cells w h ich are lost during  the physiologic turnover
CHAPTER 1: INTRODUCTION
(Ronconi et at, 2009). Besides the role o f renal progenitors in  the 
physiologic repair o f damaged glom erular cells, increasing in terest is 
aroused in  determ ining the pathogenetic role o f these cells in  d iffe ren t 
g lom erular diseases. Recently, in  a study conducted in  collaboration w ith  
the group o f Dr. Smeets and D r. Romagnani, we have investigated the 
localization o f CD24+CD133+ progenitor cells, w h ich in  norm al kidneys 
line the hum an Bowman's capsule (Sagrinati et al., 2006), in  biopsies o f 
patients w ith  d iffe ren t podocytopathies and crescentic 
glom erulonephritis. By using confocal m icroscopy, laser capture 
m icrodissection, and real-tim e quantita tive reverse transcriptase-PCR, we 
demonstrated tha t crescentic lesions o f patients are m ain ly constituted by 
progenitor cells, w h ich pro life ra te  in  the fa iled  attem pt to  replace the 
in ju red  glom erular cells (Smeets et at, 2009).
U nderstanding the mechanisms o f crescentic lesion fo rm ation  is 
p ivo ta l in  the search o f therapies to protect patients against h igh -risk  
progressive renal fa ilu re  avo id ing the use o f currently em ployed toxic 
drugs.
1.4 Role o f chem okines in  the p ro life ra tive  pathw ay
Leukocyte tra ffick in g  from  peripheral b lood in to  affected tissues is 
an essential component o f the in flam m atory reaction to v irtu a lly  a ll form s 
o f in ju ry  and is an im portan t factor in  the developm ent o f m any k idney
9
CHAPTER 1: INTRODUCTION
diseases. In  the past years, evidence have h igh lighted the central role o f a 
fam ily  o f chemotactic cytokines called chemokines in  th is process (Segerer 
et al., 2000). The chemokine system in  humans comprises up to 50 sm all 
heparin-binding proteins and 20 transmembrane G prote in-coupled 
receptors tha t were o rig ina lly  iden tified  by the ir chemotactic a c tiv ity  on 
bone m arrow -derived cells (Garcia-Vicuna et al., 2004). According to the 
position and spacing o f N -term ina l cysteine residues, chemokines can be 
d iv ided  in to  C, CC, CXC, and CX3C fam ilies, and consequently, the ir 
receptors have been designated as CR, CCR, CXCR, and CX3CR (Garcia- 
V icuna et al., 2004). In  the kidneys, chemokines and the ir receptors are 
expressed by in trins ic  renal cells as w e ll as by in filtra tin g  cells during  
renal in flam m ation, and help to contro l the selective m igra tion  and 
activation o f in flam m atory cells in to  in ju red  renal tissue (Segerer et al., 
2000).
The crescentic g lom erulonephritis is a glom erular diseases w ith  an 
in flam m atory nature, characterized by massive extracapillary p ro life ra tion  
o f parie ta l ep ithe lia l cells in  the Bowman's space. G iven the w e ll know n 
a b ility  o f chemokines in  m ediating cell p ro life ra tion  and m igration, we 
suggested the ir possible involvem ent in  the developm ent o f crescentic 
lesions. In  particu la r we studied CXCR4, w h ich appears to be the m ajor 
chemokine receptor expressed on p ro life ra ting  cancer cells, and strom al- 
derived factor-1 (SDF-1) w hich is its lone ligand (Reckamp et a l, 2008). 
SDF-1/CXCR4 interactions and signalling have also been im plicated as a 
p rinc ipa l axis regulating retention, m igration and m obiliza tion  of
10
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hem atopoietic stem cells du ring  steady-state homeostasis and in ju ry  
(Lapidot et ah, 2005). M ice lacking CXCR4 or SDF-1 have a le tha l defect o f 
colonization o f em bryonic bone m arrow  by hem atopoietic stem cells and 
im paired vascular developm ent (Ratajczak et al., 2006). In  a previous 
study, the expression o f CXCR4 has been observed in  CD24+CD133+ 
progenitor cells isolated from  healthy hum an g lom eru li (M azzingh i et al., 
2008). In  SCID mice w ith  acute renal fa ilu re , in travenously injected renal 
progenitor cells engraft in to  in ju red  renal tissue and prevent renal fibrosis. 
M ig ra tion  o f CD24+CD133+ cells in to  the g ra ft was dram atica lly reduced 
by b locking CXCR4 w ith  a neu tra liz ing  antibody, suggesting the essential 
role o f CXCR4 in  the therapeutic hom ing o f hum an renal p rogen ito r cells 
(M azzinghi et al., 2008).
G iven the key ro le o f CXCR4 in  m ediating cell p ro life ra tio n  in  
various cell types, CXCR4 in h ib itio n  may be a po tentia l therapeutic 
approach to decrease cell p ro life ra tion  and m igration, possib ly lim itin g  
the form ation o f extracapillary crescentic lesions.
1.5 Role o f ACE in h ib ito rs  in  rena l disease rem ission and regression
1.5.1 Evidence in  anim al m odels
N ephron loss w h ich  characterizes the progression o f renal diseases, 
leads to an adaptation process o f the rem aining nephrons in c lud ing  
glom erular hypertension and enlargem ent o f the pores perfo ra ting  the
11
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glom erular barrier. The consequent loss o f size-selective properties leads 
to  an excessive accum ulation o f u ltra filte red  proteins in  the Bowman's 
space and in  the lum en o f tubules, contribu ting  to exacerbate renal 
damage through the recru itm ent o f in flam m atory cells and activation of 
apoptotic pathways (Perico et ah, 2008).
Pharmacological treatments aim ed at reducing glom erular 
hypertension and pro te in  tra ffick in g  through the glom erular filtra tio n  
barrier, are effective in  lim itin g  renal function  deterioration and thus 
prom oting k idney repair. The cornerstone o f current treatm ent is 
represented by the in h ib itio n  o f angiotensin I I  (Ang II), w h ich is the key 
player o f the renin-angiotensin system (RAS). Ang II  in h ib itio n  may occur 
through tw o  d iffe ren t classes o f drugs. The firs t class is represented by 
ACE inh ib ito rs, w h ich prevent the synthesis o f Ang II  by b locking the 
action o f the enzyme w h ich converts A ng I in to  Ang I I  (Tsukamoto et ah, 
2011). The second class includes the A ng II  type I  receptor blockers 
(ARBs), w h ich conversely in h ib it the ac tiv ity  o f Ang I I  by b locking its  
chemical receptors on the sm all arteries.
Evidence in  anim al models o f non-diabetic and diabetic 
nephropathies has clearly shown that treatm ent w ith  ACE inh ib ito rs, 
ARBs or the com bination o f the tw o drugs, no t on ly prevents progressive 
renal damage, b u t also promotes regression o f glomerulosclerosis and 
vascular lesions (M arinides et ah, 1990; Remuzzi et al., 1999; Remuzzi et ah, 
2002; Adamczak et al., 2003; Boffa et ah, 2003; Remuzzi et ah, 2006). In  
MW F rats, w h ich  are genetically program m ed to develop renal in ju ry  w ith
12
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age, three-dim ensional reconstruction o f the glom erular cap illa ry tu ft 
based on serial section analysis o f hundreds o f g lom eru li, has 
demonstrated tha t ACE in h ib ito r reduced the glom erular volum e 
occupied by sclerosis in  para lle l w ith  a substantial increase in  the volum e 
occupied by in tact capillaries, suggesting a rem odelling o f the glom erular 
architecture and generation o f new cap illa ry netw ork (Remuzzi et al., 
2006). The effectiveness o f Ang I I  antagonists to prom ote regression o f 
glomerulosclerosis m ay be attributable to a decreased extracellu lar m a trix  
deposition through a reduced expression o f plasm inogen activator 
inh ib ito r-1  (Ma et al., 2000), collagen I  and IV  and transform ing g row th  
factor-p (TGF- p) (Remuzzi et al., 2006), and an increased m etalloproteinase 
ac tiv ity  (Boffa et al., 2003). Conversely, the recovery of glom erular lesions 
could be due to an effect o f ACE in h ib ito r in  m odulating g lom erular ce ll 
p ro life ra tion  and surviva l. Accord ingly, previous data have described 
regeneration o f glom erular capillaries as a resu lt o f lim ite d  mesangial cell 
p ro life ra tion  and endothelial cell repopulation induced by
pharm acological treatm ent w ith  ACE in h ib ito r (Adamczak et al., 2003). 
M ore recent evidence indicates tha t ACE in h ib ito r halts mesangial ce ll 
hyperplasia, induces glom erular endothelia l cell rem odelling, and 
increases the num ber o f podocytes (Macconi et al., 2009). These data 
indicate the effectiveness o f ACE in h ib ito r to induce neoform ation o f 
healthy glom erular tissue.
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1.5.2 Evidence in  humans
The effectiveness o f ACE in h ib ito r to  lim it renal disease progression 
has been also described in  patients w ith  p ro te inuric  non-diabetic and 
diabetic nephropathies. The R am ipril Efficacy in  Nephropathy (REIN) 
study showed tha t ACE in h ib ito r halves the rate o f renal function loss in  
patients w ith  non-diabetic chronic nephropathies (The GISEN group, 1997; 
Ruggenenti et a l, 1998; Ruggenenti et a l, 1999). Renoprotection is a 
function o f tim e and in  patients on continued ra m ip ril therapy fo r at least 
5 years, the rate o f GFR decline progressively im proved (Ruggenenti et a l, 
1999) to levels comparable to physiologic, age-related loss o f GFR 
observed in  subjects w ith  no evidence o f renal disease. In  ten of these 
patients, there was a breakpoint ind ica ting  the transition  from  an in itia l 
phase o f progressive GFR loss to a second phase o f progressive function 
im provem ent, suggesting the possib ility  o f regression o f renal lesions 
combined to some degree o f k idney regeneration (Remuzzi A  et al, 2006).
W ilm er and coworkers demonstrated tha t 8-year treatm ent w ith  
ACE in h ib ito r stabilizes kidney function in  patients w ith  type 1 diabetes 
and nephrotic syndrome, who generally progress to ESRD. The possib ility 
to prom ote kidney repair in  patients w ith  type 1 diabetes has been 
suggested long tim e ago in  a study w h ich demonstrated the im provem ent 
o f typ ica l lesions o f diabetic glom erulopathy after ten years of 
norm oglycem ia fo llo w in g  pancreas transplantation (Fioretto et al, 1998).
The efficacy of com bined therapy w ith  h igh dose o f ACE in h ib ito r 
w ith  ARB and diuretics in  im proving  c lin ica l outcome was demonstrated
14
CHAPTER 1: INTRODUCTION
fo r the firs t tim e in  a single in d iv id u a l w ith  ra p id ly  w orsening renal 
function  (Ruggenenti et al., 2001). Subsequently, m u ltim oda l therapy was 
fo rm a lly  compared w ith  treatm ent w ith  ACE in h ib ito r alone in  a large 
cohort o f patients w ith  severe chronic kidney disease (Ruggenenti et al., 
2008). Over a seven-year fo llo w  up, on ly tw o  ou t o f 56 patients on the 
integrated protocol have progressed to ESRD compared to 17 ou t o f 56 
reference patients. M oreover, GFR has been stabilized in  26 patients, and 
th is was taken to indicate rem ission o f the disease and the poss ib ility  o f 
k idney repair in  th is popula tion (Ruggenenti et al., 2008). This therapeutic 
program  has been named Remission Clinic and is curren tly  im plem ented at 
least to  some extent even in  "em erging" countries (Lim esh et a l, 2012) 
where dialysis and transplantation are s im p ly no t available to m ost 
patients.
1.6 Role o f renal p rogen ito r cells in  k id n e y  repa ir
In  a physio logica l setting, the kidney has been considered as an 
organ w ith  m in im a l cell tu rnover and w ith  a consequent lim ite d  a b ility  fo r 
self-repairing. However, after ischem ia/reperfusion in ju ry , an increased 
tubu lar cell p ro life ra tion  occurs resulting in  regeneration o f tubules 
starting from  the th ird  day. A fte r 10 days, 50% o f the tubules have been 
regenerated (Ysebaert et al, 2000) whereas the complete tubu la r structure 
restoration has been reached after 4 weeks (Humes et ah, 1994; W itzga ll R
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et al., 1994). This a b ility  o f the kidney to self-regenerate supports the 
hypothesis that resident cells m ay be invo lved in  norm aliz ing structure 
and function after an insu lt.
D iffe ren t theories are try in g  to elucidate whether reparative 
program m e depends on cells orig ina ting  from  de-d ifferentia tion of 
tubu lar cells, from  extrarenal stem cells that are recruited to the kidney 
fo llo w in g  damage, or from  progenitor cells resid ing in  specific niches in  
the kidney.
1.6.1 D e -d iffe re n tia tio n  o f tu b u la r cells
Term inally d ifferentia ted tubu lar cells that survive to damage m igh t 
pro life ra te and generate identica l cells or de-differentiate and 
subsequently re-enter the cell cycle. A fte r the insu lt, renal tubu lar cells 
ra p id ly  lose the ir brush border and de-differentiate in to  cells w ith  
mesenchymal phenotype, w ith  re-expression o f V im entin, Pax-2 and 
neural cell adhesion m olecule (NCAM ), that norm ally are no t expressed in  
m ature tubules (W itzga ll et al., 1994; Im grund et al., 1999; Abbate M  et ah, 
1999). The loss o f the h ig h ly  specialized phenotype is reflected also by 
decreased expression o f the apical brush border markers, gp330 and DPP- 
IV . D e-differentiated tubu lar cells seem to m igrate in to  regions where 
tubu lar basement membrane is denudated fo llo w in g  to detachment of 
necrotic and apoptotic cells. There, the release o f grow th factors such as 
in su lin -like  grow th factor-1 and hepatocyte grow th factor, promotes cell
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pro life ra tion  and re-d iffe ren tia tia tion  in to  an ep ithe lia l phenotype (Schena 
et al., 1998), com pleting the repair process (Cantley et al., 2005).
1.6.2 R ecruited extra-renal stem cells
In  add ition  to the a b ility  o f tubu la r cells to  self-repairing, em erging
theories have shown tha t bone m arrow -derived stem cells contribute to 
cell tu rnover and regeneration after in ju ry  o f several regions o f the k idney 
(De Broe et ah, 2005). Poulsom et al. have dem onstrated tha t k idney of 
female m ice, tha t has received a male bone m arrow  transplant, shows co­
localization o f Y chromosomes and the tubu lar ep ithe lia l m arker Lens 
Culinaris lectin. M oreover, Y chrom osom e-containing tubu la r ep ithe lia l 
cells has been observed in  k idney suffe ring damage in  male patients w ho 
had received kidney transplants from  female donors (Poulsom et ah, 2001). 
M ore recently, i t  has been dem onstrated tha t in  female m ice le tha lly  
irrad ia ted  and transplanted w ith  male bone m arrow  cells, the num ber o f Y 
chrom osom e-positive tubu la r cells increases fo llo w in g  fo lic  acid-induced 
tubu lar in ju ry  in  the recip ient mouse, and tha t some of these cells undergo 
d iv is ion  w ith in  the tubule. However, they note tha t renal tubu la r 
regeneration m ain ly came from  female resident cells, as the cells invo lved  
in  tubule repair seem to  be Y-chromosome-negative (Fang et ah, 2005).
C onflic ting  results are reported by d iffe ren t groups, and nowadays 
it  is no t clear whether these cells, com ing from  the bone m arrow , are 
already present in  the k idney p rio r to in ju ry , function ing  as resident stem
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cells, o r whether they are recruited to the k idney at the tim e o f in ju ry  
(Poulsom et al., 2002).
1.6.3 Resident renal p rogen ito r cells
A  stem cell is defined as a cell that, upon d iv is ion, can self-renew and 
give rise to a transit-am p lify ing  progenitor, tha t subsequently acquires a 
m ore d ifferentiated state. Stem cells resid ing in  adu lt organs fo rm erly  
believed to have no regenerative potentia l, have been considered as 
m u ltipo ten t precursors having the a b ility  to  m aintain, generate and 
replace m ature cells w h ich have been lost as a consequence of 
physiologica l cell turnover or tissue in ju ry  (Blau et al., 2001).
In  the adu lt kidney, resident stem /progen itor cells have been 
id en tified  through the expression o f stem-cell markers or fo r the presence 
o f functiona l properties o f stem cells, as the lo w  cell cycle. In  the recent 
years several studies have been focused on the search o f renal m u ltipo ten t 
progenitor cells in  the adu lt kidney, revealing the presence o f d iffe ren t 
popula tion o f im m ature cells in  d is tinct sites o f the nephron, in c lud ing  the 
g lom eru li, the tu bu li, the in te rs titium  and the renal pap illa  (Table 1) 
(Benigni et ah, 2010).
The presence o f a subset o f m u ltipo ten t progenitor cells in  the adu lt 
hum an g lom eru li has been demonstrated fo r the firs t tim e by the group of 
D r. Romagnani. These cells, located in  the inner surface o f the Bowman's 
capsule, express the stem cell markers CD24 and CD133, and the
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transcrip tion factors Oct-4 and B m l-l (Sagrinati et ah, 2006). Isolated 
CD24+CD133+ PECs exhibited clonogenic self-renewal and are able to  
generate podocytes and tubu lar cells in vitro. M oreover, when injected in to  
SCID mice w ith  acute kidney in ju ry , these cells induce tubu la r 
regeneration and am elioration o f k idney structure (Sagrinati et ah, 2006). 
The Bowman's capsule o f healthy g lom eru li is no t on ly composed by 
CD24+CD133+ PECs, bu t three d is tinct subpopulation o f PECs has been 
described, expressing variable levels o f stem cell and podocyte markers 
(Ronconi et ah, 2009). A  hierarchical organization have been proposed, 
w ith  im m ature progenitor cells (expressing CD24 and CD133 in  the 
absence o f podocyte m arkers nestin and podocalyxin) present closest to 
the u rina ry  pole, transitiona l cells (expressing both stem cell and podocyte 
markers) located between the u rina ry  and the vascular pole, and 
d ifferentia ted podocytes on ly expressing nestin and podocalyxin near the 
vascular pole (Ronconi et ah, 2009). Genetic labe lling  has been 
subsequently used to m ark the cells o f the Bowman's capsule and 
irreversib ly track the ir progeny in  new born and adolescent m ice, 
dem onstrating tha t PECs m igrate in to  the glom erular tu ft to become 
podocytes. These fin d in g  provide evidence tha t these cells are responsible 
fo r podocyte renewal (Appel et ah, 2009).
A  d iffe ren t theory has a ttribu ted  to cells o f the renin lineage, 
norm ally resid ing in  the juxtag lom erular com partm ent alongside the 
glom erular capillaries, the capacity to enhance glom erular regeneration 
after podocyte depletion (P ippin et ah, 2013). A fte r a decreased podocyte
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num ber, a sign ificant increase in  the num ber o f renin-expressing cells have 
been observed in  g lom eru li in  a focal d is tribu tion  along the Bowman's 
capsule or w ith in  the glom erular tu ft, re-expressing the podocyte markers 
WT-1, nephrin  podocin and synaptopodin (P ipp in  et ah, 2013).
A  m icroarray analysis conducted on glom erular and tubular 
fractions o f hum an kidneys has allow ed the identifica tion  of 
CD24+CD133+ progenitor cells no t on ly in  the Bowman's capsule b u t also 
in  proxim al tubules (Sallustio et ah, 2010). The characterization o f these 
cells has been subsequently perform ed by L indgren and coworkers on 
hum an cells isolated on the basis o f the h igh  aldehyde dehydrogenase 
(ALD H ) ac tiv ity  (Lindgren D et ah, 2011). K idney cells w ith  A LD H high 
a c tiv ity  isolated from  the renal cortex, d isp lay sphere form ation and 
anchorage-independent grow th, tw o classic stem cell fuctiona l properties. 
The analysis o f the whole-genome expression p ro file  o f A LD H hish cells 
shows h igh  levels o f CD24, CD133, v im en tin  and cytokeratins 19, markers 
tha t are also expressed in  the metanephric mesenchyme during  
nephrogenesis (Lindgren D  et ah, 2011). W hether these tubular-com m itted 
progenitor cells can be d istinguish from  CD24+CD133+ progenitors lin in g  
the inner surface o f the Bowman's capsule has been recently studied by 
A nge lo tti and coworkers (A nge lo tti et ah, 2012). A  screening o f hundreds 
o f genes has been perform ed on CD24+CD133+ cells isolated from  the 
glom erular or from  the tubu lar compartments. The analysis has revealed 
tha t some genes were d iffe ren tia lly  expressed, and among these, the 
expression o f CD106 was approxim ately 300-fold higher in  cells obtained
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from  glom erular outgrow ths than in  cells obtained from  tubu la r tissue 
(A nge lo tti et al., 2012). W hile CD24+CD133+CD106+ progenitor cells o f the 
Bowman's capsule exh ib it an h igh p ro life ra tive  rate and could 
d ifferentiate towards both the podocyte and the tubu la r lineages, 
CD24+CD133+CD106- scattered cells o f the tubules show a low er 
p ro life ra tive  capacity and display a com m itted phenotype towards the 
tubu la r lineage. W hen injected in to  SCID mice w ith  acute tubu la r in ju ry , 
both o f these ce ll populations engraft the k idney and integrate in  tubules 
(A nge lo tti et al., 2012).
A  d iffe ren t strategy fo r the iden tifica tion  o f progenitor cells in  the 
adu lt k idney has been based on the property o f stem cells to cycle 
in frequently to m ainta in the poo l o f cells fo r tissue turnover and repair. 
C ycling cells can be iden tified  by the a b ility  to reta in the p ro life ra tive  
m arker brom odeoxyuridine (BrdU), previously injected to the animals. On 
the basis o f th is concept, Maeshima et al. dem onstrated the existence o f 
label-reta in ing cells in  proxim al and d ista l tubules o f healthy ra t kidneys 
(Maeshima et al., 2003). Further studies showed the presence also in  the 
in te rs titium  o f slow -cycling cells, w h ich after uretera l obstruction re­
expressed the mesenchymal ce ll markers v im en tin  and e-cadherin 
(Yamashita et al., 2005). The same approach has been used by O live r and 
coworkers to demonstrate that the renal pap illa  is a niche fo r a d u lt k idney 
stem cells. In  m ice and rats pulse-chased w ith  BrdU , lo w  cycling cells have 
been found very sparse in  the kidney except fo r the renal pap illa  (O live r et 
al., 2004). D uring  the repair phase o f transient renal ischaemia, these cells
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enter the cell cycle and the BrdU  signal qu ick ly  disappears from  the 
pap illa , suggesting tha t they can be invo lved in  k idney repair. Isolated 
renal pap illa ry  cells d isplay a plastic phenotype and have the a b ility  to 
fo rm  spheres like  other stem cell types. In  add ition , once injected in to  the 
renal cortex they incorporate in to  the renal parenchyma (O liver et a l, 
2004).
The last approach tha t has been used to id e n tify  and isolate 
progenitor cells in  the adu lt kidney is based on the a b ility  o f stem cells to 
extrude a Hoechst dye (Goodell et al., 1996). Several populations of 
Hoechstlow stem cells, term ed side populations, have been found located in  
renal in te rs titium  (Iw atan i et al, 2004). D ifferent studies have documented 
the beneficial effect o f side populations in  anim al models o f kidney 
diseases as adriam ycin nephropathy (Challen et al, 2006), cisplatin- 
induced acute kidney in ju ry  (H ishikaw a et al, 2005) and chronic kidney 
disease (Im ai et al, 2007), b u t probably th is phenomenon m igh t be only 
due to a paracrine effect o f the cells.
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Species Markers Localization Reference
Human CD133+CD24+ Bowman's capsule Sagrinati et al., 2006
Mouse Renin Juxtaglomerular compartment Pippin etai., 2013
Human CD133+CD24+ Bowman's capsule 
Proximal and distal tubule
Sallustio e ta i, 2010
Human CD133+CD24+CD106+ 
CD24+CD133+CD106-
Bowman's capsule 
Proximal and distal tubule
Angelotti e ta i, 2012
Human Aldehyde dehydrh'9hCD24+CD133++ Proximal tubules Lindgren et al. 2011
Rat BrdU (slow-cycling cells) Proximal and distal tubules Maeshima et al., 2003
Rat slow-cycling cells Interstitium Yamashita etai., 2005
Rat Hoechst'™ (side population) Interstitium Iwatani et al., 2004
Rat/Mouse BrdU (slow-cycling cells) Papilla Oliver et al., 2004
Table 1. Localization o f renal progenitor cells in  the adu lt kidney
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2.1 Rats
- M ale W istar and MW F rats were bred at the IRCCS -  Is titu to  d i Ricerche 
Farmacologiche M ario N egri, starting from  animals in itia lly  purchased 
from  Charles R iver Ita lia  s.p.a., Calco, Ita ly.
2.2 Cells
- Rat progenitor cells were isolated from  the outgrow th o f contro l W istar 
rats (Methods, section 3.8).
2.3 Fixatives
- D uboscq-B razil so lu tion  ready to use, was purchased from  DiaPath, 
M artinengo, Bergamo, Ita ly .
- Paraform aldehyde was purchased from  Electron M icroscopy Sciences, 
H a tfie ld , PA, USA. In  order to prepare a 4% solution, we d ilu te d  8% 
aqueous so lu tion in  PBS 2X under a fum e hood.
Im m unogo ld  fixa tive : 3.5% paraform aldehyde plus 0.01%
glutaraldehyde. G lutaraldehyde was purchased from  Sigma A ld rich , St 
Louis, M O, USA.
- F ixative fo r in vitro cells: 2% paraform aldehyde + 4% sucrose.
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2.4 M edia, supplem ents and reagents fo r in vitro study
- m edium  p lus endothe lia l g row th  m edium -m icrovascular (EG M - 
M V ) was purchased from  Lonza W alkersville, USA
- D M E M  was purchased from  S igm a-A ldrich
- V R A D  m edium : DM EM /F12 supplem ented w ith  v itam in  D3 100 
n m o l/L  and retinoic acid 100 jim o l/L
- Fetal bovine serum was purchased from  Thermo Scientific, 
Rockford, IL , USA.
- B lock ing  so lu tion : 2% BSA, 0.2% gelatin bovine, and 2% FBS in  PBS
- F ib ronectin  from  ra t plasma was purchased from  S igm a-A ldrich
- Goat a n ti-ra b b it IgG  M icroBeads was purchased from  M ilte n y i 
Biotech Inc, Auburn, CA, USA
- A ng io tensin  I I  was purchased from  S igm a-A ldrich and used at a 
fin a l consentration o f 10'7 m o l/L .
- P erm eab iliz ing so lu tion : TRITON X100 was purchased from  Sigma- 
A ld rich  and was d ilu ted  to a fin a l concentration o f 0.3% in  PBS IX .
2.5 Chemicals
- P ara ffin , B ioplast Plus, was purchased from  Bio Optica, M ilan, Ita ly.
- U nyho l Plus B ioplast Plus, was purchased from  Bio Optica.
- E thanol was purchased from  Carlo Erba, M ilan, Ita ly.
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- M ethanol was purchased from  Carlo Erba.
- Acetone was purchased from  Carlo Erba.
- Periodic acid was purchased from  D iapath, M artinengo, Bergamo, Ita ly
- Schiff's reagent was purchased from  Kaltek srl, Padova, Ita ly
- Sodium hyposolfite was purchased from  M erck, M ilan , Ita ly . A  5% 
so lu tion was prepared by d issolving the pow der in  water.
- Piero Indigo Carmine was purchased from  Bio-Optica.
- Sucrose was purchased from  Sigma A ld rich .
- Coomassie brillian t blue dye was purchased from  S igm a-A ldrich.
- Carazzi haematoxylin was purchased from  Bio-Optica.
- Harris haematoxylin was purchased from  Bio-Optica.
- Orthophosphoric acid was purchased from  M erck, M ilan , Ita ly .
- Hydrogen peroxide (H 2O2) so lu tion was purchased from  S igm a-A ldrich.
- Propylene oxide (1,2-epoxypropane), Electron M icroscopy Sciences, 
EMS, Rome, Ita ly.
- OSO4 was purchased from  Electron M icroscopy Sciences.
- Uranyl acetate was purchased from  Electron M icroscopy Sciences.
2.6 Buffers and solutions
- Phosphate b u ffe r saline (PBS) 10X (for ce ll cu ltu re  and 
im m unohistochem istry) was purchased from  A m bion-Invitrogen. F ina lly, 
PBS IX  is prepared d ilu tin g  1:10 PBS 10X in  water.
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- C itrate b u ffe r 10% concentrated pH  6.0, was d ilu ted  1:10 in  PBS IX  and 
was purchased from  DiaPath.
- B lock ing  b u ffe r. Bovine serum album in (BSA) (S igm a-Aldrich) was 
added to PBS to obtain a fin a l BSA concentration o f 1%. The solution was 
m aintained on ice fo r few  m inutes to facilita te  album in solubilisation. The 
solution was then filte red  w ith  a 0.2 pm sterile filte r.
- 3 ,3 '-d iam inobenzid ine (DAB). One tablet o f DAB was p u t in to  25 m l o f 
d is tilled  water. Solution was m ixed and 6.5 p i o f 30% H 2O2 was added. 
DAB was purchased from  Merck.
- Cacodylate b u ffe r 0.2 M . Sodium  cacodylate trihydra te  12.84 g, Sigma- 
A ld rich , + 300 m l o f water. pH  was stabilized at 7.4 w ith  HC1 0.2 N  
(Merck).
- Cacodylate b u ffe r 0.1M pH  7.4. Prepared by d ilu tin g  (1:1) in  w ater 
cacodylate bu ffe r 0.2 M , pH  7.4
- Epon resin. Solution 1: 5 m l o f Durcupam  ACM , Fluka (S igm a-Aldrich) + 
18 m l o f Epoxy Em bedding M edium , Hardener DDSA, Fluka. Solution 2: 6 
m l of Epoxy Em bedding M edium , Fluka + 300 p i o f Epoxy Em bedding 
M edium  Accelerator, Fluka. F inally, so lu tion 1 and 2 were m ixed.
2.7 A n tibod ies
For a ll antibodies, p re lim inary experiments were perform ed fo llo w in g
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m anufacturer's suggestions in  order to id e n tify  the m ost appropriate 
experim ental protocol and concentration.
2.7.1 P rim ary antibodies:
- Rabbit an ti-W ilm 's  tum or 1, purchased from  Santa Cruz Biotechnology, 
Santa Cruz, CA, USA. F inal concentration: 1:50.
- Rabbit a n ti-c la u d in l, purchased from  Therm o Scientific. U ndilu ted.
- Mouse or goat anti-CD24, purchased from  Santa Cruz Biotechnology. 
F inal concentration: 1:25.
- Mouse a n ti-T h y l.l antibody was purchased from  BD Biosciences. F inal 
concentration 1:100.
- Mouse a n ti-E D l antibody, purchased from  Chemicon International, 
Temecula, CA, USA. F inal concentration 1:100.
- Mouse anti-B rdU  antibody was purchased from  BD Biosciences. F inal 
concentration 1:100.
- Mouse anti-N C A M , purchased from  Developm ental Studies H ybridom a 
Bank, U n iversity o f Iowa, USA. F inal concentration: 1:2.
- Rabbit anti- hum an CXCR4 antibody purchased from  Abeam, and used 
at the concentration o f 1:50.
- Rabbit an ti-A T i receptor purchased from  Santa Cruz B iotechnology. 
F inal concentration: 1:25.
- Rabbit anti-SDF-1 antibody was purchased from  Abeam. F inal 
concentration 1:200.
- Goat an ti-N ephrin , purchased from  Santa C ruz Biotechnology. F inal
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concentration: 1:400.
- Rabbit anti-Type I I I  collagen antibody was purchased from  Chemicon 
International. F inal concentration 1:100.
- Rabbit anti-C/EBPS, purchased from  Santa Cruz Biotechnology. Final 
concentration: 1:25.
- Mouse anti-Synaptopodin purchased from  Progen Biotechnik GmbFL 
U ndiluted.
- Rabbit anti-Phospho-histone H3 was purchased from  C ell S ignalling 
Technology. F inal concentration 1:100.
- Mouse anti-CD133 was purchased from  M ilte n y i Biotech Inc. F inal 
concentration 1:100.
- Mouse anti-CD68 was purchased from  DakoCytom ation, G lostrup 
Denmark. F inal concentration 1:100.
2.7.2 Secondary antibodies:
- Cy3-conjugated goat anti rabbit IgG , purchased from  Jackson 
ImmunoResearch Laboratories and used at fin a l concentration o f 1:50.
- Cy3-conjugated donkey anti mouse IgG, purchased from  Jackson 
ImmunoResearch Laboratories and used at fin a l concentration o f 1:150.
- Cy3-conjugated donkey anti goat IgG , purchased from  Jackson 
ImmunoResearch Laboratories and used at fin a l concentration o f 1:300.
- FITC-conjugated goat anti mouse IgG , purchased from  Jackson 
ImmunoResearch Laboratories and used at fin a l concentration of 1:50.
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- FITC-conjugated goat a n ti ra b b it IgG , purchased from  Jackson 
ImmunoResearch Laboratories and used at fin a l concentration o f 1:50.
- FITC-conjugated ra b b it a n ti goat IgG , purchased from  Jackson 
ImmunoResearch Laboratories and used at fin a l concentration o f 1:50.
- Cy5-conjugated donkey an ti-ra b b it antibody purchased from  Jackson 
ImmunoResearch Laboratories and used at fin a l concentration o f 1:50.
- B io tin y la ted  sheep anti-m ouse IgG , purchased from  Jackson 
ImmunoResearch Laboratories and used at fin a l concentration o f 1:75.
- B io tin y la ted  goat a n ti-ra b b it IgG , purchased from  Jackson 
ImmunoResearch Laboratories and used at fin a l concentration o f 1:150.
- 12-nm gold-conjugated donkey anti-goat IgG , purchased from  Jackson 
ImmunoResearch Laboratories and used at fin a l concentration o f 1:20.
2.8 O ther reagents
- L is in o p ril was dissolved in  d rink ing  w ater at concentration o f 80m g/L.
- R a m ip ril was used at increasing doses starting from  2.5 to 7.5 m g / day.
- A za th ioprine  was used at a concentration o f 50 m g / day.
- 5-brom o-2-deoxyuridine (BrdU) was purchased from  S igm a-A ldrich. It  
was injected to the animals at concentration o f 50 m g /k g  dissolved in  
saline, 5 days before sacrifice.
- Tissue-Tek OCT Com pound was purchased from  Sakura Finetek, 
Torrance, CA, USA.
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- Eukitt was purchased from  Bio Optica.
- Vectastain avidin-biotin peroxidase complex solution (ABC) k it 
purchased from  Vector Laboratories, Burlingam e, CA, USA.
- Fluorescence mounting medium was purchased from  DakoCytom ation.
- FITC-labeled lectin W heat Germ Agglutinin (W GA) was purchased 
from  Vector Laboratories. F inal concentration 1:400.
■- Rhodamine-labelled Lectin Lens Culinaris Agglutinin (LCA) was 
purchased from  Vector Laboratories.. F inal concentration 1:400.
- DAPI: 4/,6/-diam idino-2-phenylindole d ihydrochloride hydrate was 
purchased from  S igm a-A ldrich.
2.9 Disposable materials
- F ilte r paper 3M M , purchased from  W hatman.
- Plastic cuvettes were purchased from  DISA RAffaele e F .lli s.a.s.
- Polyethylene labelled-cone shaped capsules were purchased from  
Electron M icroscopy Sciences.
- Formvar were purchased from  Electron M icroscopy Sciences.
2.10 Instruments
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- A utoanalyzer fo r serum  creatin ine and u rin a ry  p ro te in  concentration 
measurement: Synchron CX9 system was purchased from  Beckman 
C oulter, Fullerton, USA.
- M icrotom e, RM2255, was purchased from  Leica M icrosystems.
- C ryostat, CM1950, was purchased from  Leica M icrosystems.
- U ltram icrotom e EM UC7, was purchased from  Leica M icrosystems.
- ApoTom e M od A xio  Im ager Z2, was purchased from  Zeiss, Jena, 
Germany.
- Confocal laser-scanning m icroscope LS 510 Meta; was purchased from  
Zeiss.
- E lectron m icroscope M orgagni 268D was purchased from  Philips, Brno, 
Czech Republic.
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M ethods fo r in vivo studies in  the experim ental ra t m odel
3.1 M un ich  W ista r From ter rats
M ale W istar and M unich W istar From ter (MWF) rats (M aterials, 
section 2.1) were used. S ixty MW F rats were d iv ided  in to  d iffe ren t groups 
as fo llow s:
• group 1 (n = 50) received saline and were sacrificed at d iffe ren t
tim e points, 10, 25, 40, 50, and 60 weeks o f age (n = 10 rats fo r
each tim e point);
• group 2 (n = 10) received lis in o p ril (M aterials, section 2.8, 80
m g /L  in  d rink ing  w ater) from  50 to 60 weeks o f age;
• group 3 (n = 20) 10,25,40,50, and 60-week-old W istar rats were
used as controls.
To study cell p ro life ra tion , W istar and MW F rats given vehicle or 
lis in o p ril from  50 to 60 weeks o f age (n = 4 fo r each group) were injected 
in traperitonea lly w ith  an S-phase labeled 5-brom o-2-deoxyuridine (BrdU, 
M aterials, section 2.8, 50 m g /k g  dissolved in  saline) fo r 5 days before 
sacrifice. Anim als were housed in  a constant tem perature room  w ith  a 12- 
hour dark 12-hour lig h t cycle and fed a standard diet. A n im a l care and 
treatm ent were in  accordance w ith  in s titu tio n a l guidelines in  com pliance 
w ith  national (D.L. n.116, G.U., supp l 40,18 February 1992, C ircolare No. 
8, G.U., 14 July 1994) and in terna tiona l laws and policies (EEC C ouncil
36
CHAPTER 3: METHODS
D irective 86/609, OJL 358, Dec 1987; N IH  G uide fo r the Care and Use o f 
Laboratory Anim als, U.S. N ational Research Council, 1996). A n im al 
studies were subm itted to and approved by the Institu tiona l A n im al Care 
and Use Comm ittee o f the "M ario  N egri" Institu te , M ilan, Ita ly.
3.2 Renal fu n c tio n  measurement
To assess renal function, we measured to ta l u rina ry  pro te in  excretion 
rate by using the Coomassie b rillia n t blue dye-binding assay. Coomassie 
b rillia n t blue (50 mg; M aterials, section 2.5) was dissolved in  50 m l 
orthophosphoric acid 99% 16 M  (M aterials, section 2.5) and 46.7 m l 
absolute ethanol (M aterials, section 2.5) then d ilu ted  to 1 L w ith  water. 
The solution was filte red  through W hatman paper (M aterials, section 2.9) 
and stored in  dark-colour glass bottles, m ainta in ing rigorous cleanliness. 
The ha lf-life  o f the so lution is several weeks, bu t re filte ring  m ay be 
required i f  p recip ita tion  o f dye occurs. The assay was perform ed in  plastic 
cuvettes (M aterials, section 2.9). Coomassie b rillia n t blue dye-reagent (2 
m l) was added to  50 p i o f urine samples. In  each evaluation 1 sample o f 
water alone and 3 samples w ith  bovine serum album in (BSA) (M aterials, 
section 2.6) at know n concentrations (50, 100 and 200 p g /m l) were 
included to obtained the standard curve. Samples were always assayed in  
trip lica te . The colour developm ent is essentially complete at 5 m inutes and
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remains stable fo r a period o f 2 hours. The absorbance at 578 nm  was 
measured at the spectrophotometer. The concentration o f proteins present 
in  the samples o f in terest was obtained taking  in to  account the absorbance 
values derived from  the standard curve in  w h ich the BSA concentrations 
were know n.
Creatinine is an endogenous substance m ain ly produced in  muscle 
cells from  creatine and phosphocreatine. The serum creatinine 
concentration rises w ith  the decline o f GFR, because creatinine is excreted 
m ain ly by glom erular filtra tio n . Here the serum creatinine concentration 
was measured using an autom atic device w ith  a quantita tive, co lorim etric 
assay based on a m odified Jaffe m ethod where alkaline picrate form s a 
reddish colored so lu tion in  the presence o f creatinine. The measurement 
was perform ed im m ediate ly after the taking  o f the sample. Blood pressure 
was evaluated by ta il plethysm ography in  awake animals.
3.3 Sacrifice and tissue co llection
W istar and MW F rats were sacrificed by exposure to CO2 at 10, 25, 
40, 50 or 60 weeks o f age. Kidneys were weighed and in  order to  take 
samples representative o f the d iffe ren t s tructura l components o f the 
kidney, sections were cut in  the axial coronal plane. Depending on the 
type of procedure tha t w ou ld  have been applied (im m unohistochem istry, 
im m unofluorescence, electron m icroscopy), samples were d iffe re n tly  fixed
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as described in  each specific chapter.
3.4 Renal m orphology by lig h t m icroscopy
Im m ediate ly after collection, kidney fragments were fixed  overnight 
in  Duboscq-Brazil so lu tion (M aterials, section 2.3) and then dehydrated by 
ascending concentrations o f ethanol (M aterials, section 2.5) (70% and 100% 
fo r 2 hours each). Once dehydrated, samples were dipped in  U nyhol Plus 
(M aterials, section 2.5) fo r 1 hour, transferred to stainless steel base 
m oulds, covered by para ffin  (M aterials, section 2.5), and fin a lly  incubated 
fo r 2 hours at 60°C. D uring  th is period o f tim e para ffin  in filtra tes  the 
sample. Samples were then placed at room  tem perature to a llow  para ffin  
to so lid ify . Embedded samples were cut in  3 pm thickness slices by using 
a m icrotom e (M aterials, section 2.10).
For the h isto logic staining, sections were deparaffinised in  U nyhol 
Plus (M aterials, section 2.5) fo r 20 m inutes and then rehydrated in  
decreasing concentrations o f ethanol (M aterials, section 2.5, 100% fo r 10 
m inutes, fo llow ed by 90 and 80% fo r 5 m inutes each) and water. Samples 
were than incubated fo r 10 m inutes w ith  1% periodic acid (Materials, 
section 2.5) and washed 5 m inutes in  d is tille d  water. Slides were then 
stained w ith  period ic acid-S chiff s (PAS) (M aterials, section 2.5) reagent 
fo r 1 hour and washed three times fo r 5 m inutes each w ith  sodium
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hyposulphite (M aterials, section 2.5), rinsed in  tap w ater fo r 5 m inutes, 
and then in  d is tille d  w ater fo r another 5 m inutes. N ucle i were stained by 
p lacing glass slides in  Carazzi haem atoxylin (M aterials, section 2.5) fo r 10 
m inutes. A fte r rins ing  in  water, samples were qu ick ly im m ersed in  Piero 
Ind igo  Carm ine (M aterials, section 2.5) fo llow ed by 100% ethanol and 
U nyhol Plus, and fin a lly  m ounted w ith  E u k itt (M aterials, section 2.8).
Slides were scored fo r the fo llo w in g  changes: synechiae (th in  
connections between glom erular Bowman's capsule and the cap illa ry tu ft), 
and crescents (m ultilayers o f cells accum ulating in  the inner surface o f the 
Bowman's capsule, w h ich obliterate the Bowman's space).
To evaluate the extent o f glom erular lesions, an average o f 35 
g lom eru li was examined and data were expressed as index. Each 
glom erulus was scored according to the extension o f glom erular lesions as 
fo llow s: 0 = absence o f lesions; 1 = lesions affecting less than 25% o f 
glom erulus; 2 and 3 = lesions affecting >25 to 50% and >50 to 75% o f the 
glom erulus, and 4 = lesions exceeding 75% o f the glom erulus. The index 
fo r synechiae and crescents were calculated by using the fo llo w in g  
form ula:
index= (1 x n i)+  (2 x n 2)+ (3 x 113)+ (4 x 114) /  no+ n i+  n 2+ n3 + 114
W here nx = num ber o f g lom eru li in  each grade o f lesions (Davis et 
al., 2004). Sections were analysed in  a sing le-b lind fashion. Renal h is to logy 
pictures were acquired w ith  a fluorescence and optica l m icroscope
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(ApoTome, M aterials, section 2.10).
3.5 Im m unohistochem istry
3.5.1 Im m unofluorescence
For a ll immunofluorescence experiments, k idney samples collected 
im m ediate ly after ra t sacrifice, were fixed  in  4% paraform aldehyde (PFA, 
M aterials, section 2.3) overn ight at 4°C, washed tw ice fo r 10 m inutes in  
PBS, in filtra te d  w ith  30% sucrose (M aterials, section 2.5), embedded in  
Tissue-Tek OCT Com pound (M aterials, section 2.8) and fin a lly  frozen in  
liq u id  nitrogen. Three-m icrom eter-thick sections were cut by using a 
cryostat (M aterials, section 2.10) and stored at -80°C. The antigen re trieva l 
was perform ed in  citrate bu ffe r (M aterials, section 2.6) 10 m m o l/L  (pH 
6.0) at bo ilin g  temperature fo r 20 m inutes, fo llow ed by incubation w ith  
citrate bu ffe r (20 m inutes) at room  temperature to enhance the reactiv ity 
o f antibodies to antigens. To block nonspecific sites, sections were treated 
w ith  1% BSA (M aterials, section 2.6) fo r 30 m inutes at room  temperature 
and then incubated w ith  the fo llow ing  prim ary antibodies.
W T1. Sections were incubated overn ight at 4°C (or 3 hours at room  
tem perature in  case o f co-incubation w ith  other antibodies) w ith  rabb it 
an ti-W ilm 's  tum or 1 antibody (M aterials, section 2.7.1) d ilu ted  1:50 in  
PBS1X. Subsequently, k idney samples were treated w ith  goat anti rabbit- 
Cy3 antibody (M aterials, section 2.7.2), Donkey anti rabbit-Cy5 antibody
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(M aterials, section 2.7.2), or goat an ti rabbit-FITC antibody (M aterials, 
section 2.7.2), fo r 1 hour at room  temperature.
C la u d in l. Sections were incubated overn ight at 4°C w ith  und ilu te d  rabb it 
an ti-c la ud in l antibody (M aterials, section 2.7.1). Subsequently, kidney 
samples were treated w ith  goat an ti rabbit-Cy3 antibody (M aterials, 
section 2.7.2) or goat an ti rabbit-FITC  antibody (M aterials, section 2.7.2), 
fo r 1 hour at room  temperature.
CD24. Sections were incubated overn ight at 4°C w ith  mouse anti-CD24 
antibody (M aterials, section 2.7.1) d ilu ted  1:25 in  PBS1X. Subsequently, 
k idney samples were treated w ith  goat an ti mouse-FITC antibody 
(M aterials, section 2.7.2) fo r 1 hour at room  temperature.
T h y l.l. Sections were incubated overn ight at 4°C w ith  mouse a n ti-T h y l.l 
antibody (M aterials, section 2.7.1) d ilu ted  1:50 in  PBS1X. Subsequently, 
k idney samples were treated w ith  donkey an ti mouse-Cy3 antibody 
(M aterials, section 2.7.2) fo r 1 hour at room  temperature.
E D I. Sections were incubated overn ight at 4°C (or 3 hours at room  
tem perature in  case o f co-incubation w ith  other antibodies) w ith  mouse 
an ti-E D l antibody (M aterials, section 2.7.1) d ilu ted  1:100 in  PBS1X. 
Subsequently, k idney samples were treated w ith  Donkey an ti mouse-Cy3 
antibody (M aterials, section 2.7.2) or goat an ti mouse-FITC antibody 
(M aterials, section 2.7.2), fo r 1 hour at room  temperature.
BrdU . Sections were incubated 1 hour at room  tem perature w ith  mouse 
anti-B rdU  antibody (M aterials, section 2.7.1) d ilu ted  1:50 in  PBS1X.
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Subsequently, k idney samples were treated w ith  Donkey anti mouse-Cy3 
antibody (M aterials, section 2.7.2) fo r 1 hour at room  temperature.
N C A M . Sections were incubated 1 hour at room  tem perature w ith  mouse 
anti-N C A M  antibody (M aterials, section 2.7.1) d ilu ted  1:2 in  PBS1X. 
Subsequently, k idney samples were treated w ith  Donkey anti mouse-Cy3 
antibody (M aterials, section 2.7.2), or goat anti mouse-FITC antibody 
(M aterials, section 2.7.2), fo r 1 hour at room  temperature.
CXCR4. Sections were incubated overn ight at 4°C w ith  mouse anti-CXCR4 
antibody (M aterials, section 2.7.1) d ilu ted  1:25 in  PBS1X. Subsequently, 
k idney samples were treated w ith  Donkey anti mouse-Cy3 antibody 
(M aterials, section 2.7.2) fo r 1 hour at room  temperature.
A T i receptor. Sections were incubated overnight at 4°C w ith  rabb it anti- 
A T i receptor antibody (M aterials, section 2.7.1) d ilu ted  1:25 in  PBS1X. 
Subsequently, k idney samples were treated w ith  goat an ti rabbit-FITC 
antibody (M aterials, section 2.7.2) fo r 1 hour at room  temperature.
SDF-1. Sections were incubated 1 hour at room  tem perature w ith  rabb it 
anti-SDF-1 antibody (M aterials, section 2.7.1) d ilu ted  1:100 in  PBS1X. 
Subsequently, k idney samples were treated w ith  goat an ti rabbit-Cy3 
antibody (M aterials, section 2.7.2) fo r 1 hour at room  temperature.
N ephrin . Sections were incubated overnight at 4°C w ith  goat anti-nephrin 
antibody (M aterials, section 2.7.1) d ilu ted  1:100 in  PBS1X. Subsequently, 
k idney samples were treated w ith  rabb it anti goat-FITC antibody 
(M aterials, section 2.7.2) fo r 1 hour at room  temperature.
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Slides were then washed w ith  PBS1X and incubated fo r 15 m inutes at 
room  tem perature w ith  FITC- or rhodam ine-conjugated lectin  W heat 
Germ A g g lu tin in  (W GA, M aterials, section 2.8), w h ich  by b ind ing  
membrane glycoproteins and sialic acid, was used to better id e n tify  renal 
structures. N ucle i were subsequently stained w ith  4 ',6 '-d iam id ino-2- 
phenylindole d ihydroch loride hydrate fo r 15 m inutes at room  
tem perature (DAPI, M aterials, section 2.8). Sections were fin a lly  washed 
w ith  PBS IX  and m ounted w ith  the DAKO  fluorescence m ounting 
m edium  (M aterials, section 2.8). Negative controls were obtained by
om itting  the prim ary antibody on adjacent sections. D u ring  the
experim ent, slides were always kept in  a m oist chamber to avoid the
hydra tion  o f the sections. Slides were analyzed by an inverted confocal 
laser-scanning microscope (M aterials, section 2.10). Q uantifica tion o f cells 
positive fo r the d iffe ren t m arkers was perform ed in  at least 30 random ly 
selected g lom eru li per each animal.
3.5.2 Im m unoperoxidase
For im m unoperoxidase experiments, renal tissues were fixed  
overnight in  Duboscq-Brazil, dehydrated in  alcohol and embedded in  
para ffin  as previously described (M ethods, section 3.4). Three-
m icrometers th ick sections were deparaffin ized in  U nyhol Plus, 
rehydrated and incubated fo r 30 m inutes at room  tem perature w ith  0.3% 
H 2O2 (M aterials, section 2.5) d ilu ted  in  m ethanol (M aterials, section 2.5). 
This step is necessary to quench endogenous peroxidase found in  m any
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tissues and avoid aspecific signal. Antigen re trieva l was perform ed using 
a m icrowave (2x5 m inutes in  citrate buffer at an operating frequency o f 
2450 M H z and a 600 W  pow er output) and citrate buffer incubation (15 
m inutes at room  temperature, M aterials, section 2.6) to increase the 
reactiv ity  o f antibodies to antigens. To block nonspecific sites, sections 
were treated w ith  1% BSA (M aterials, section 2.6) fo r 30 m inutes at room  
tem perature and then incubated overnight a t 4°C w ith  the fo llow ing  
prim ary antibodies.
Type I I I  collagen. Sections were incubated overn ight at 4°C w ith  rabb it 
anti-type I II  collagen antibody (M aterials, section 2.7.1) d ilu ted  1:100 in  
PBS1X. Subsequently, kidney samples were treated w ith  goat an ti rabbit- 
b io tinyla ted  antibody (M aterials, section 2.7.2) fo r 1 hour at room  
temperature.
C/EBPS. Sections were incubated overn ight at 4°C w ith  rabb it anti- 
C/EBPS antibody (M aterials, section 2.7.1) d ilu ted  1:100 in  PBS1X. 
Subsequently, k idney samples were treated w ith  goat an ti rabbit- 
b io tiny la ted  antibody (M aterials, section 2.7.2) fo r 1 hour at room  
temperature.
A fte r washing in  PBS IX , slides were incubated w ith  av id in -b io tin  
peroxidase complex so lution (ABC) (M aterials, section 2.8) lin k in g  the 
b io tiny la ted  secondary antibody, fo r 30 m in  at room  temperature. The 
staining was visualized using diam inobenzidine (DAB) (M aterials, section
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2.6) substrate solution, tha t reacts w ith  the peroxidase producing a brow n 
end product. The reaction o f the substrate was m onitored by observing 
sections at lig h t m icroscopy, and then blocked by im m ersing slices in  
d is tilled  water. This step is im portan t to determ ine the rig h t period o f 
reaction tha t was then applied to  a ll slices. A fte r rinsed in  w ater, samples 
were counterstained w ith  H arris haem atoxylin (M aterials, section 2.5), 
qu ick ly  dehydrated w ith  100% ethanol (M aterials, section 2.5) and U nyho l 
Plus (M aterials, section 2.5), and fin a lly  m ounted w ith  E u k itt (M aterials, 
section 2.8). Negative controls were obtained by om itting  the p rim ary  
antibody on adjacent sections. D uring  the experim ent, the slides were 
always kept in  a m oist chamber to avoid tha t the sections could dehydrate. 
Q uantification o f cells positive fo r the m arkers was perform ed in  at least 
30 random ly selected g lom eru li per each anim al.
C/EBP8 signal on the Bowman's capsule was graded on a scale o f 0 to 3 
(0: no C/EBP8 -positive cells, 1: <25% positive cells, 2: 25% to 50% positive  
cells, 3: >50% positive cells in  the Bowman's capsule).
3.6 Im m unogold
For im m unogold staining, sm all fragm ents o f k idney tissue tha t 
averaged 0.5-1 m m  thickness, were fixed  overn ight at 4°C in  3.5% 
paraform aldehyde plus 0.01% glutaraldehyde (M aterials, section 2.3)
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overnight at 4°C, and washed repeatedly in  0.1 M  cacodylate buffer, pH  
7.4 (Materials, section 2.6) in  order to stabilize the sample and prevent 
degradation. Specimens were post-fixed in  1% OsC>4 (M aterials, section
2.5) fo r 1 hour. This step confers s tab ility  du ring  the fo llow ing  steps o f 
dehydration and em bedding and provides electron contrast.
Specimens were dehydrated through ascending grades o f alcohol: 
10% fo r 10 m inutes, 50% and 70% fo r 10 m inutes each, 90% and 100% fo r 
15 m inutes each. Samples were then placed in  propylene oxide (1,2- 
epoxypropane) (M aterials, section 2.5), a flu id  m iscible w ith  both alcohol 
and epoxy resin, and embedded in  Epon resin (M aterials, section 2.6) 
overnight at room  tem perature that m aintains the resin in  a liq u id  state to 
better in filtra te  the sample. Polyethylene labelled-cone shaped capsules 
(M aterials, section 2.9) containing fresh ly prepared resin was used to 
contain the samples. Tissue fragments were placed at the tip  o f the 
truncated cone tha t was fille d  w ith  em bedding therm osetting synthetic 
resins. A fte r 3 days du ring  w h ich tim e the samples were incubated at 60°C 
to a llow  polym erisation and so lid ifica tion  o f the resin, the blocks o f resin 
were cut by ultram icrotom e (M aterials, section 2.10) and then transferred 
to n ickel grids coated w ith  Form var (M aterials, section 2.9). A fte r b locking 
w ith  1% BSA fo r 15 m inutes, sections were incubated overnight w ith  goat 
anti-nephrin (M aterials, section 2.7.1) fo llow ed by 12-nm gold-conjugated 
donkey anti-goat secondary antibody (M aterials, section 2.7.2) fo r 1 hour 
at room  temperature. The grids were washed w ith  PBS1X, stained fo r 5 
m inutes w ith  2% aqueous u ranyl acetate (M aterials, section 2.5), and
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examined w ith  a M orgagni 268D electron m icroscopy (M aterials, section 
2.10).
3.7 S ta tistica l analysis
Results are expressed as means ±SE. C orrelation analysis between 
index o f crescents and p ro te inuria  was perform ed by evaluating Pearson's 
r coefficient, using a M icrosoft Excel spreadsheet. Statistical analysis o f 
A T i receptor quantifica tion was perform ed using analysis o f variance w ith  
the Bonferroni post hoc analysis fo r m u ltip le  comparisons. P rote inuria 
levels, synechiae, and crescents were analyzed using 2-way A N O V A . The 
nonparam etric K ruskal-W allis and M ann-W hitney tests were applied, as 
appropriate. The statistical significance level was defined as P<0.05.
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M ethods fo r in vitro  studies in  the experim ental ra t m odel
3.8 Cells and ce ll cu lture
Kidneys o f adu lt W istar rats were qu ick ly removed, and the cortex 
homogenate was gently pressed through a 105-pm (140 mesh) sieve and 
then over a 75-pm (140 mesh) sieve that retains glom eru li. G lom eruli were 
then centrifuged, resuspended in  m edium  plus endothelial grow th 
m edium -m icrovascular (EGM-MV, M aterials, section 2.4) and 20% feta l 
bovine serum (FBS, M aterials, section 2.4), and plated on fibronectin- 
coated dishes (10 [xg/m L, M aterials, section 2.4) at a density o f 200 
g lom eru li/100-m m  plate. A fte r 5 to 7 days of culture, ce llu lar outgrow th 
observed on adherent capsulated glom eru li, was harvested and cultured 
in  EG M -M V 20% FBS on glass coverslips coated w ith  fibronectin.
For d iffe ren tia tion  and p ro life ra tion  experiments, cells from  
glom erular outgrow th have been expanded and c laud in l-pos itive  cells 
were obtained by im m unom agnetic separation using goat anti-rabb it IgG 
MicroBeads (M aterials, section 2.4) according to the m anufacturer's 
protocol. The cells obtained from  the second passage o f c la u d in l+ cell 
fraction were used fo r a ll experiments. For podocyte d iffe rentia tion, 
c la u d in l+ PECs were treated fo r 7 days w ith  D M EM /F12 supplemented 
w ith  v itam in  D3 100 n m o l/L  and retinoic acid 100 jim o l/L  (VRAD 
m edium , M aterials, section 2.4). The p ro life ra tion  rate o f im m unoisolated
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c la u d in l+ PECs was assessed by evaluating the phosphoryla tion at SerlO 
o f histone H3 in  cells m aintained overn ight in  m edium  plus 1% FBS and 
then exposed to m edium  or to angiotensin I I  (10'7 m o l/L , M aterials, 
section 2.4) fo r 24 hours.
The expression o f C/EBPS was evaluated in  PECs incubated in  
DM EM  (M aterials, section 2.4) plus 2% BSA, exposed or no t w ith  10'7 
m o l/L  angiotensin I I  (M aterials, section 2.4). A fte r 6 hours, the cells were 
fixed  and processed as described in  M ethods, section 3.9.
3.9 Im m unofluorescence
For im m unofluorescence analysis, cells were fixed  in  2% 
paraform aldehyde plus 4% sucrose (M aterials, section 2.3) and 
perm eabilized w ith  0.3% T riton - X100 (M aterials, section 2.4). A fte r 
b locking the non-specific sites w ith  2% BSA plus 0.2% gelatin bovine and 
2% FBS in  PBS, cells were incubated w ith  the fo llo w in g  p rim ary 
antibodies:
C la u d in l. The expression o f c la u d in l was evaluated in  cells obtained from  
the outgrow th o f capsulated glom eru li. Cells were incubated 1 hour at 
room  tem perature w ith  und ilu ted  rabb it a n ti-c la u d in l antibody 
(M aterials, section 2.7.1). Subsequently, cells were treated w ith  goat an ti
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rabbit-Cy3 antibody (M aterials, section 2.7.2), fo r 1 hour at room 
temperature.
N C A M . The expression o f N C A M  was evaluated in  cells obtained from  
the outgrow th o f capsulated glom eru li. Cells were incubated 1 hour at 
room  tem perature w ith  mouse anti-N C A M  antibody (M aterials, section
2.7.1) d ilu ted  1:2. Subsequently, cells were treated w ith  goat an ti mouse- 
FITC antibody (M aterials, section 2.7.2), fo r 1 hour at room  temperature. 
CD24. The expression o f CD24 was evaluated in  cells obtained from  the 
outgrow th  o f capsulated glom eruli. Cells were incubated w ith  mouse anti- 
CD24 antibody (M aterials, section 2.7.1) d ilu ted  1:25, overn ight at 4°C. 
Subsequently, cells were treated w ith  goat anti mouse-FITC antibody 
(M aterials, section 2.7.2), fo r 1 hour at room  temperature.
Synaptopodin. The expression o f synaptopodin (SYN) was evaluated in  
c laud in l-pos itive  cells obtained by the im m unom agnetic separation using 
MicroBeads. Cells were incubated w ith  und ilu ted  mouse anti-SYN 
antibody (M aterials, section 2.7.1), overnight at 4°C. Subsequently, cells 
were treated w ith  goat anti mouse-FITC antibody (M aterials, section
2.7.2), fo r 1 hour at room  temperature.
Phospho-histone H3. The expression o f phospho-histone H3 (H3p) was 
evaluated in  c laud in l-pos itive  cells obtained by the im m unom agnetic 
separation using MicroBeads. Cells were incubated w ith  und ilu ted  rabb it 
anti-H 3p antibody (M aterials, section 2.7.1), overnight at 4°C. 
Subsequently, cells were treated w ith  goat anti rabbit-FITC antibody 
(M aterials, section 2.7.2), fo r 1 hour at room  temperature.
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C/EBP5. The expression o f C/EBP5 was evaluated in  cells obtained from  
the outgrow th o f capsulated g lom eru li, treated or no t w ith  Angio tensin II. 
Cells were incubated 3 hours at room  tem perature w ith  rabb it anti- 
C/EBP5 antibody (M aterials, section 2.7.1) d ilu ted  1:25. Subsequently, 
cells were treated w ith  goat an ti rabbit-FITC  antibody (M aterials, section
2.7.2), fo r 1 hour a t room  temperature.
N ucle i were then stained w ith  D A P I (M aterials, section 2.8) fo r 15 
m inutes at room  temperature. F ina lly, cells were washed w ith  PBS IX  and 
m ounted w ith  the DAKO  m ounting m edium  (M aterials, section 2.8). 
Representative images were acquired using an inverted confocal laser 
scanning microscope (M aterials, section 2.10).
The quantifica tion o f cells positive fo r SYN or H3p was assessed 
evaluating fluorescent cells per to ta l D A P I+ cells in  each h igh-pow er fie ld  
(HPF) (five to 10 fie ld s /s lid e ; n = 3 experiments). Data were expressed as 
percentage o f SYN+H3p+ cells on to ta l DAPI+ cells, per each HPF.
3.10 S ta tistica l analysis
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Results are expressed as means ±SE. Statistical analysis was 
perform ed using student's t-test. The statistical significance level was 
defined as P<0.05.
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M ethods fo r in vivo studies in  hum an tissue
3.11 Patients
T h irty  six patients w ith  p ro life ra tive  and non p ro life ra tive  
glom erulopathies from  the archives o f the U n it o f Nephrology, O spedali 
R iu n iti o f Bergamo, Ita ly , were enrolled in  the study. Patients were 
d iv ided  in to  d iffe ren t groups as fo llow s:
• Patients w ith  extracapillary p ro life ra tive  lesions as:
1) extracapillary g lom erulonephritis (n=9)
2) IgA  nephropathy (n=9).
• Patients w ith  non p ro life ra tive  diseases as:
1) membranous nephropathy (n=7)
2) diabetic nephropathy (n = ll) .
W ritten  in form ed consent was obtained from  a ll these patients. In  
add ition , to fu rthe r address the possible partic ipa tion  o f the A ng I I /  A T i 
receptor pathw ay and renal progenitor cells in  the developm ent o f 
g lom erular hyperplastic lesions, we analyzed in-depth renal tissue 
specimens from  one o f these patients w ith  an tineutroph il cytoplasm  
antibodies (AN C A)-positive crescentic g lom erulonephritis from  w hom  
tw o biopsies were collected, before and after 8 months therapy w ith  the 
ACE in h ib ito r ra m ip ril (titra tin g  up the dose from  2.5 to 7.5 m g / day, 
M aterials, section 2.8) associated w ith  the im m unosuppressant
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azathioprine (50 m g/day). A ll kidney biopsy specimens considered fo r the 
present study had been o rig ina lly  obtained fo r the diagnosis o f renal 
disease. In  add ition  to specimens from  patients w ith  p ro life ra tive  and non 
pro life ra tive  diseases, renal biopsies from  an un invo lved po rtion  of 
kidney collected from  tum or nephrectomy specimens were obtained from  
10 patients and used as controls.
3.12 Dem ographic and c lin ica l characteristics o f p a tien t popula tions
For a ll patients enrolled in  the study, dem ographic, c lin ica l and 
hematochemical parameters at the tim e o f renal biopsy were retrieved 
from  the H ospita l database. Demographic parameters taken in to  account 
were the age o f patients reported as range o f years-old, and the gender 
expressed as ra tio  between male and female (M:F). The clin ica l parameters 
evaluated in  the patients, quantified by the Laboratories o f the D iv is ion  of 
N ephrology and D ialysis o f the hospital, were systolic and diastolic blood 
pressure, p ro te inuria  and serum creatinine.
3.12.1 E valuation o f system ic b lood pressure
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Systemic blood pressure was measured by sphygmomanometer. The 
blood pressure levels reflect the values o f systolic and diasto lic pressure. 
Systolic pressure refers to systole, the phase when the heart pum ps blood 
out in to  the aorta. D iastolic pressure refers to diastole, the resting period 
when the heart re fills  w ith  blood. A  typ ica l b lood pressure reading o f a 
healthy adu lt should be 120 m illim eters o f m ercury (m m Hg) o f systolic 
blood pressure and 80 m m H g o f d iasto lic blood pressures. The values 
vary depending on age and m any other factors.
3.12.2 Assessment o f u rin a ry  p ro te in  concentrations
U rina ry p ro te in  concentration, collected fo r 24 hours (h), was 
measured using an autoanalyzer (M aterials, section 2.10). The test used is 
based on the procedure developed by Watanabe et al (Watanabe et at, 
1986). This is a dye-b inding m ethod tha t generate a com plex o f purp le  
colour w ith  the proteins content in  the sample. The resu lting com plex has 
a m axim um  absorbance at 600 nanometers (nm). The system autom atically 
apportions the sample and reagent in to  a cuvette at a ra tio  o f 1:30 fo r u rine  
samples. The system m onitors the change in  absorbance at 600 nm  at a 
fixed-tim e in terva l. The change in  absorbance is d irec tly  p ropo rtiona l to 
the concentration o f pro te in  in  the sample and is used by the system to 
calculate and express the pro te in  concentration.
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3.12.3 Assessment o f serum creatin ine concentrations
The serum creatinine concentration was measured in  patients using 
an autom atic device (M aterials, section 2.10) w ith  a quantitative, 
colorim etric assay based on a m od ified  Jaffe m ethod where alkaline 
picrate form s a reddish colored so lu tion in  the presence o f creatinine. A  
precise volum e o f sample is autom atically in troduced by Synchron CX 
System in to  a reaction cup containing the alkaline picrate so lution in  the 
ra tio  o f 1:11. The system reads the alterations o f the absorbance at both 520 
nm  and 560 nm. These alterations are d irectly  proportiona l to the 
creatinine concentration o f the samples.
3.13 B iopsy and tissue co llection
Depending on the type o f procedure that w ou ld  have been applied 
(im m unohistochem istry or immunofluorescence), samples were frozen in  
liq u id  n itrogen or embedded in  para ffin  as described in  each specific 
chapter.
3.14 Renal m orphology by lig h t m icroscopy
Im m ediate ly after collection, kidney fragments were fixed overnight 
in  Duboscq-Brazil so lu tion (M aterials, section 2.3), dehydrated and
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embedded in  pa ra ffin  (M aterials, section 2.8) as previously described 
(Methods, section 3.4). Embedded samples were cut a t 2 pm thickness 
slices by using a m icrotom e (M aterials, section 2.10).
For the histo logic staining, sections were deparaffinised, rehydrated 
and undergone to PAS (M aterials, section 2.5) staining as previously 
described (Methods, section 3.4). Slides were observed w ith  lig h t 
m icroscopy (M aterials, section 2.10), and quantified as the percentage of 
g lom eru li affected by d iffe ren t glom erular lesions: extracapillary 
p ro life ra tion  (m ultilayers o f cells accum ulating in  the inner surface o f the 
Bowman's capsule, w h ich obliterate the Bowman's space), global sclerosis 
(accum ulation o f PAS-positive m aterials in  the entire glom erular tu ft), 
segmental sclerosis (accum ulation o f PAS-positive m aterials in  a restricted 
area o f the glom erular tu ft), other glom erular changes (cap illa ry loop 
thickening, mesangial hype rce llu la rity  and m atrix  expansion, ep ithe lia l 
vacuolization). In  add ition , the percentage o f norm al g lom eru li has been 
also quantified.
3.15 Im m unoh istochem istry
3.15.1 Im m unofluorescence
For a ll im m unofluorescence experiments, samples collected 
im m ediate ly after renal biopsy, were embedded in  Tissue-Tek OCT
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Com pound (M aterials, section 2.8) and frozen in  liq u id  nitrogen. Two- 
m icrom eter-thick sections were cu t by using a cryostat (M aterials, section 
2.10) and stored at -80°C. Sections were a ir dried, fixed  in  cold acetone 
(M aterials, section 2.5), and washed in  PBS IX  and incubated w ith  1 % BSA 
as previously described (Methods, section 3.5.1). Slides were then 
incubated w ith  the fo llo w in g  p rim ary antibodies.
CD24. Sections were incubated 1 hour at room  tem perature w ith  goat or 
mouse anti-CD24 antibody (M aterials, section 2.7.1) d ilu ted  1:25 in  PBS1X. 
Subsequently, kidney samples were treated w ith  donkey anti goat-Cy3 
antibody (M aterials, section 2.7.2) or goat an ti mouse-FITC antibody 
(M aterials, section 2.7.2), fo r 1 hour at room  temperature.
CD133. Sections were incubated 1 hour at room  temperature w ith  mouse 
anti-CD133 antibody (M aterials, section 2.7.1), d ilu ted  1:50. Subsequently, 
kidney samples were treated w ith  donkey anti mouse-Cy3 antibody 
(M aterials, section 2.7.2) fo r 1 hour at room  temperature.
CXCR4. Sections were incubated overn ight at 4°C w ith  rabb it anti-CXCR4 
antibody (M aterials, section 2.7.1) d ilu ted  1:50 in  PBS1X. Subsequently, 
kidney samples were treated w ith  goat anti rabbit-FITC antibody 
(M aterials, section 2.7.2) fo r 1 hour at room  temperature.
SDF-1. Sections were incubated overn ight at 4°C w ith  rabb it anti-SDF-1 
antibody (M aterials, section 2.7.1) d ilu ted  1:200 in  PBS IX . Subsequently, 
kidney samples were treated w ith  goat anti rabbit-Cy3 antibody 
(M aterials, section 2.7.2) fo r 1 hour at room  temperature.
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CD68. Sections were incubated 1 hour at room  tem perature w ith  mouse 
anti-CD68 antibody (M aterials, section 2.7.1), d ilu ted  1:100. Subsequently, 
k idney samples were treated w ith  goat an ti mouse-FITC antibody 
(M aterials, section 2.7.2) fo r 1 hour at room  temperature.
N ephrin . Sections were incubated overn ight at 4°C w ith  goat an ti-nephrin  
antibody (M aterials, section 2.7.1) d ilu ted  1:100 in  PBS1X. Subsequently, 
k idney samples were treated w ith  rabb it an ti goat-FITC antibody 
(M aterials, section 2.7.2) fo r 1 hour at room  temperature.
A T i receptor. Sections were incubated overnight at 4°C w ith  rabb it anti- 
A T i receptor antibody (M aterials, section 2.7.1) d ilu ted  1:25 in  PBS1X. 
Subsequently, k idney samples were treated w ith  goat an ti rabbit-FITC  
antibody (M aterials, section 2.7.2) fo r 1 hour at room  tem perature.
Slides were then washed w ith  PBS1X and incubated fo r 15 m inutes at 
room  tem perature w ith  FITC- or rhodam ine-conjugated lectin  W heat 
Germ A g g lu tin in  and w ith  D A P I (M aterials, section 2.8) as previously 
described (Methods, section 3.5.1). Sections were fin a lly  washed w ith  PBS 
IX  and m ounted w ith  the m ounting m edium  D AKO  (M aterials, section
2.8). Negative controls were obtained by om itting  the p rim ary antibody on 
adjacent sections. Slides were analyzed by an inverted confocal laser- 
scanning microscope (M aterials, section 2.10). For SDF-1 expression in  
patients w ith  extracapillary glom erulonephritis and in  norm al kidneys, a ll 
g lom eru li o f the section were acquired and subjected to sem i-quantita tive
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analysis. G lom erular SDF-1 expression was scored on a scale o f 0 to 3 (0: 
no staining, 1: m ild , 2: moderate, 3: strong diffuse staining).
3.15.2 Im m unoperoxidase
For A T i receptor evaluation, Duboscq-Brazil-fixed kidney biopsies 
were embedded in  para ffin  (M aterials, section 2.8), and sections were 
subsequently deparaffin ized, rehydrated and incubated fo r 30 m inutes at 
room  tem perature w ith  0.3% H 2O2 (M aterials, section 2.5) d ilu ted  in  
m ethanol as described (Methods, section 2.5). Antigen re trieva l was 
perform ed using a m icrowave, and 1% BSA was applied to block 
nonspecific sites (Methods, section 2.6). Sections were then incubated 
overnight at 4°C w ith  rabb it an ti-A T i receptor antibody (M aterials, section
2.7.1) d ilu ted  1:25 in  PBS1X. Subsequently, kidney samples were treated 
w ith  goat anti-rabb it b io tinyla ted  antibody (M aterials, section 2.7.2) fo r 1 
hour at room  temperature.
A fte r washing in  PBS IX , slides were incubated w ith  ABC (M aterials, 
section 2.8), and the staining was visualized using DAB (M aterials, section
2.6) substrate so lution as described (Methods, section 3.5.2). Samples were 
counterstained w ith  H arris haem atoxylin (M aterials, section 2.5), qu ick ly  
dehydrated w ith  100% ethanol (M aterials, section 2.5) and U nyhol Plus 
(M aterials, section 2.5), and fin a lly  m ounted w ith  E u k itt (M aterials, section
2.8). Negative controls were obtained by om itting  the prim ary antibody on 
adjacent sections.
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3.16 S ta tistica l analysis
Results are expressed as mean ± SD. Statistical analysis o f A T i 
receptor quantification in  experim ental animals was perform ed using 
A N O V A  w ith  the Bonferroni post hoc analysis fo r m u ltip le  comparisons. 
The Student's t-test was app lied fo r SDF-1 quantifica tion in  patients. 
Statistical significance was defined as P<0.05.
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3.17 P rincip les o f the m ain instrum ents
3.17.1 L ig h t m icroscopy
A  microscope is an instrum ent tha t allows observation o f objects 
that are too sm all to be seen by the naked eye. In  order to visualise objects, 
the lig h t m icroscope uses lig h t and m agnifying lenses. M ost microscopes 
are composed by tw o lens systems: the objective lens and the ocular. The 
fin a l m agnification o f an object results by the m u ltip lica tion  of the 
m agnifying pow er o f the objective lens (from  4x to lOOx) and the 
m agnifying power o f the ocular lens (from  8x to 12x). As a result, a 
standard microscope provides a fin a l m agnification range o f 40x up to 
lOOOx.
The essential factor fo r producing a good image is the ligh t. The 
microscope uses another lens, the condenser, to produce a b righ t and 
un ifo rm  lig h t illu m in a tin g  the specimen. A  good image is obtained when 
the resolution is high. The resolution is the a b ility  to distinguish tw o 
objects as separate entities. Resolution is best when the distance separating 
the tw o tin y  objects is small.
In  th is study the lig h t miscoscopy is used to observe renal specimens 
labelled w ith  PAS sta in ing (Methods, section 3.14) or im m unoperoxidase 
techniques (Methods, section 3.15.2). The PAS is a staining m ethod used to 
detect polysaccharides such as glycogen, and mucosubstances such as 
glycoproteins, g lyco lip ids and mucins in  tissues. The Schiff reagent gives a 
purple-m agenta colour, w h ich labels the connective tissue, glycocalyx and
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basal laminae. In  the kidney, the PAS staining is com m only used to 
evaluate and quan tify  the glom erular and tubu lar damage.
3.17.2 Im m unofluorescence technique and confocal m icroscopy
This technique uses the specificity o f antibodies to the ir antigens to 
target specific cells w ith  fluorescence dyes, and therefore allow s to 
visualize the d is trib u tio n  o f the target cells through the sample. There are 
tw o  types of im m unofluorescence: the d irect im m unofluorescence and the 
ind irect one. The d irect im m unofluorescence uses a p rim ary  antibody, 
against the antigen o f interest, w h ich is d irec tly  conjugated w ith  a 
fluorophore. The in d irec t im munofluorescence, w h ich is m ore frequently 
used, employs tw o  sets o f antibodies: a p rim ary antibody and a 
subsequent, secondary, dye-coupled antibody, w h ich recognizes the 
p rim ary antibody.
Im m unofluorescent labeled samples are analyzed using fluorescence 
or confocal microscope.
A  fluorescence microscope is an optica l m icroscope used to study 
properties o f organic or inorganic substances using fluorescence and 
phosphorescence instead of, or in  add ition  to, re flection and absorption. 
The specimen is illum ina ted  w ith  lig h t o f a specific wavelength, w h ich  is 
absorbed by the fluorophores, causing them  to em it longer wavelengths o f 
lig h t (of a d iffe ren t colour than the absorbed lig h t). The illu m in a tio n  lig h t 
is separated from  the much weaker em itted fluorescence through the use
64
CHAPTER 3: METHODS
of an em ission filte r. Typical components o f a fluorescence microscope are 
the lig h t source (Xenon or M ercury arc-discharge lam p), the excitation 
filte r, the d ichroic m irro r (or dichrom atic beam splitter), and the emission 
filte r. The filte rs  and the d ichro ic are chosen to match the spectral 
excitation and em ission characteristics o f the fluorophore used to label the 
specimen.
The confocal m icroscopy is an optica l im aging technique used to 
increase m icrograph contrast a n d /o r to reconstruct three-dim ensional 
images by using a spatia l p inhole to elim inate out-of-focus lig h t or flare in  
specimens tha t are th icker than the focal plane. The p rinc ip le  o f confocal 
im aging was patented by M arv in  M insky in  1957 and aims to overcome 
some lim ita tions o f tra d itio n a l w ide -fie ld  fluorescence microscopes. In  a 
conventional fluorescence microscope, the entire specimen is flooded in  
lig h t from  a lig h t source. A ll parts o f the specimen throughout the optical 
path are excited at the same tim e and the resulting fluorescence is detected 
by the microscope's photodetector or camera in c lud ing  a large unfocused 
background part. In  contrast, a confocal m icroscope uses po in t 
illu m in a tio n  and a p inhole in  an op tica lly conjugate plane in  fro n t o f the 
detector to elim inate out-of-focus in form ation. O nly the lig h t w ith in  the 
focal plane can be detected, so the image qua lity  is m uch better than that 
o f w ide -fie ld  images. As on ly one p o in t is illum ina ted  at a tim e in  confocal 
m icroscopy, 2D or 3D im aging requires scanning over a regular raster in  
the specimen. The thickness o f the focal plane is defined m ostly by the
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square o f the num erical aperture o f the objective lens, and also by the 
optica l properties o f the specimen and the am bient index o f refraction.
3.17.3 Transm ission electron m icroscopy
The transm ission electron microscope is a type o f m icroscope that 
uses beam o f electrons to observe the specimen. The beam o f electrons, 
em itted by a h igh voltage electron em itter situated at the top o f the 
m icroscope colum n, pass through the sample and through a series of 
m agnifying magnetic lenses, to reach the v iew ing  screen where they are 
u ltim a te ly  focused. In  the colum n, a very h igh vacuum  is created in  order 
to reduce the electron beam interactions w ith  air. Energy produced by an 
electric source (~2500K) superheats a tungsten w ire  tha t em its electrons. 
L iq u id  n itrogen is used to  cool dow n the colum n fo r easier rem oval o f 
w ater vapour. Electrons are sent dow n the microscope colum n, across the 
sample, lenses, and apertures. The lenses are m agnetic coils that, set on a 
specific electron wavelength, focus and direct the electron beam. As it  
passes through the lens (three p rim ary lenses) the electron beam is sp lit. 
The topm ost lens is the objective and it  m agnifies and focuses the image. 
Then there is the interm ediate lens tha t controls the m agnification o f the 
image and the d iffraction  pattern. F ina lly, the projector lens tha t focuses 
and projects the image onto the im aging surface. The image can be 
visualized on a screen: where few er electrons were transm itted through 
the sample, in  th icker or denser zones, the image shows dark areas 
whereas areas where the sample was th inner or less dense m ore electrons
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are transm itted through and the image appears more lig h t. The power of 
resolution o f electron m icroscopy depends on the lens-systems and on 
sample preparation method. U sually, in  m odem  microscopes the 
resolution pow er ranges from  0.2 - 0.3 nm  and m agnification up to 
180,000x.
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CHAPTER 4
RESULTS IN  MW F RATS
CHAPTER 4: RESULTS
4.1 In tro d u c tio n
U n til few  years ago, the k idney has been considered as an organ w ith  
lo w  regenerative properties, and the common thought was tha t renal cells 
w h ich were lost fo llo w in g  an in ju ry  cannot be repaired. In  the recent 
years, robust evidence have documented the beneficial effect o f ACE 
inh ib ito rs  to slow  the developm ent o f p ro te inuria  and lim it renal damage, 
both in  humans (The GISEN group, 1997; Ruggenenti et ah, 1999 F ioretto et 
ah, 1998) and in  experim ental models (M arinides et ah, 1990; Rem uzzi A  et 
ah, 1999; Rem uzzi A  et ah, 2002; Adam czak et ah, 2003; Boffa et ah, 2003; 
Remuzzi A  et ah, 2006). By three-dim ensional reconstruction o f g lom erular 
cap illa ry tu fts  based on kidney serial section analysis, a group o f 
researchers o f our Insitu te has found tha t 10 week treatm ent w ith  ACE 
in h ib ito r, given to  M W F rats in  the advanced phase o f the disease, 
effectively reduced the extent o f sclerosis and induced generation o f new 
cap illa ry tissue (Remuzzi A . et ah, 2006). This approach strong ly suggests 
the poss ib ility  fo r the kidney to regenerate, however, has no t id e n tifie d  
glom erular ce llu la r components. As a fo llow -up  of that study (Rem uzzi A . 
et ah, 2006), the same group o f researchers showed that, in  M W F rats, ACE 
in h ib ito r halted the spontaneous podocyte loss and restored podocyte 
num ber (Macconi et ah, 2009).
The regression of glomerulosclerosis and neoform ation o f g lom eru lar 
tissue as been recently linked to p rogen ito r/s tem  cells o f renal or 
extrarenal o rig in  (O liver et ah, 2004).
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Mechanisms and cellu lar determ inants o f progressive nephropathies 
in  the context o f recent find ings o f glom erular ep ithe lia l cell activation 
have never been addressed in  systematic fashion. In h ib itin g  ACE can be a 
selective w ay to potentiate the regeneration o f the glom erulus, sh ifting  the 
process tow ard kidney healing. To th is end, the spontaneous 
glom erulopathy o f M W F rats represents the m ost appropriate m odel in  
w hich to study the ce llu lar basis fo r glom erular restructuring and repair.
4.2 A  popu la tion  o f renal p rogenitor cells existed w ith in  the Bowm an's 
capsule o f norm al adu lt ra t k id ney
The phenotype o f PECs in  the Bowman's capsule o f contro l W istar 
rats was assessed by sim ultaneously sta in ing c la u d in l, a m arker o f 
glom erular PECs tha t localizes to in te rce llu la r tig h t junctions (Ohse et at,
2008), and the podocyte m arker WT1. A ll o f the cells lin in g  the Bowman's 
capsule express c la u d in l, and a sm all fraction  co-expressed WT1 (21.9% + 
0.5%) (Figure 1A). That c la u d in l+W T l+ cells residing in  the inner surface 
o f the Bowman's capsule represent parie ta l podocytes was confirm ed by 
u ltrastructu ra l analysis. Through im m unogold approach we clearly 
id en tified  some PECs exhib iting foo t processes in  w hich m arked 
expression o f the s lit diaphragm  prote in  nephrin  has been found (Figure 
IB ).
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Previous studies in  humans docum ent tha t the Bowman's capsule is 
lined  by a subset o f parie ta l ep ithe lia l cells w ith  stem cell characteristics 
(Sagrinati et ah, 2006), w h ich  in  physio logica l conditions gradually lose 
the ir sternness and regenerate podocytes (Ronconi et ah, 2009). Since no 
stem cell popula tion in  the Bowman's capsule o f rats has been ever 
described, we search a m arker o f sternness in  rats, by focusing our 
attention on N C AM . N C A M  is a pro te in  expressed du ring  the kidney 
developm ent in  metanephric mesenchyme, w h ich gradually disappears 
rem aining confined in  the glom erular capsule in  m ature k idney (Abbate et 
ah, 1999; Bard et ah, 2001). In  contro l rats, N C A M  was expressed by the 
m ajority o f c la u d in l+ cells in  the Bowman's capsule (Figure 2A). Cells 
positive fo r N C A M  also expressed CD24, a surface antigen know n to  be a 
m arker o f renal progenitor cells in  m ice (Challen et ah, 2004; Swetha et ah,
2009) and in  humans (Ronconi et ah, 2009) (Figure 2B). Through a double 
im m unolabeling w ith  N C A M  and the podocyte m arker WT1, we detected 
and quantified three d is tinct populations o f cells in  the Bowm an's capsule 
(Figure 2C). The m ost abundant popu la tion  was constituted by cells on ly 
expressing N C A M  in  the absence o f WT1, representing im m ature 
progenitor cells. Two m inor cell populations were represented by 
transitiona l cells co-expressing m arkers o f renal progenitors and 
podocytes (NCAM +W T1+), and by parie ta l podocytes, tha t are m ore 
d ifferentiated cells tha t no longer expressed N C A M  b u t exhibited the 
m arker WT1 (Figure 2C). A  schematic representation o f the cell
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populations iden tified  in  the Bowman's capsule o f norm al rats was given 
in  Figure 2D.
4.3 T im e-dependent evo lu tion  o f g lom eru lar lesions in  W istar and M W F
rats
Changes in  renal h isto logy as a function  o f tim e was assessed in  
contro l W istar rats as w e ll as in  MW F rats studied at d iffe ren t tim e points 
from  10 to 60 weeks o f age (Figure 3).
In  W istar rats, the only m orphological abnorm alities observed in  
renal biopsies were synechiae, focal adhesions o f glom erular capillaries to 
the Bowman's capsule (Figure 3A). These early lesions were found 
between 50 and 60 weeks, w h ile  no more severe alterations were observed 
in  contro l animals at any other tim e p o in t (Figure 3A).
In  MW F rats, synechiae were detected starting from  10 weeks o f age, 
w h ile  from  25 weeks m ultilayers of cells accumulated at the site of 
synechiae resulting in  more severe crescentic lesions, typ ica lly  found in  
40- to 60-week-old animals (Figure 3A). The percentage o f g lom eru li w ith  
crescents was 39% + 4% at 40 weeks, 64% + 5% at 50 weeks, and 76% + 4% 
at 60 weeks. The index o f crescents, w h ich takes in to  account both the 
num ber and the extension o f glom erular lesions, positive ly correlated w ith  
the levels o f p ro te inuria  (Figure 3A and B, r = 0.94, p<0.01), w h ich
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developed w ith  tim e in  M W F rats from  10 weeks and reached values o f 
730 + 44 m g /d a y  at 60 weeks.
That crescentic lesions m ay evolve in  glom erulosclerosis was 
supported by the observation tha t type I II  collagen deposition was 
observed la ter on in  respect to the onset o f crescents (Figure 4). 
H isto log ica l analysis o f 10-week-old MW F rats revealed tha t early 
synechiae were no t associated w ith  accum ulation o f type I I I  collagen. 
From  25 weeks, crescent-like lesions were observed, w h ich  increased in  
num ber and extension w ith  age. A t an early stage, crescents were 
characterized by cell p ro life ra tion  in  the absence o f type I I I  collagen 
deposition. Lesions in  40-week-old rats were characterized by scanty 
accum ulation o f type I II  collagen, w h ich increased over tim e in  rats from  
50 to 60 weeks o f age. A t the end o f the observation period, 
glomerulosclerosis was so severe as to occupy m ost o f the g lom erular tu ft 
in  the m ajority o f the g lom eru li (Figure 4).
4.4 Phenotype o f ce ll pop u la tion  in vo lve d  in  crescentic lesions in
M W F rats
In  the past years, d iffe ren t studies analysed the ce llu la r com position 
o f crescents obtaining con flic ting  results (C atte ll et ah, 1978, Jennette et at., 
1986; Boucher et ah, 1987; Lan et ah, 1992; Ophashcharoensuk et ah, 1998; 
Le H ir et ah, 2001; M oeller et ah, 2004; Bariety et ah, 2005, Thom er et ah,
74
CHAPTER 4: RESULTS
2008). Here, we assessed the phenotype o f cells contribu ting to glom erular 
lesions in  60 week-old MW F rats by evaluating the expression o f d iffe rent 
markers (Figure 5). The m ost abundant cell popula tion was constituted by 
c la u d in l+ PECs, accounting fo r about 60% of the to ta l cells in  crescents. 
These cells m ay represent progenitor cells. A  h igh percentage o f WT1+ 
podocytes was also observed w ith in  hyperplastic lesions, and on average 
12% o f these cells co-expressed c la u d in l representing transitiona l cells. 
M esangial cells and macrophages, id en tified  respectively by T h y l.l and 
E D I im m unolabeling, represented tw o  m inor cell populations in  crescents 
(Figure 5).
4.5 Treatm ent w ith  ACE in h ib ito r reduced p ro te inu ria  and induced 
regression o f crescentic lesions
MW F rats receiving the ACE in h ib ito r lis in o p ril from  50 to 60 weeks 
o f age showed prote inuria  levels tha t were m arkedly reduced in  respect to 
those observed in  MW F rats before the beginning o f the treatm ent (Figure 
6). In  para lle l w ith  the decrease o f prote inuria , lis in o p ril lim ite d  the 
num ber and the extension of crescentic lesions, as demonstrated by the 
remarkable reduction o f the index o f crescents, w h ich reflected the degree 
o f severity o f the lesions (Figure 6). The extension o f glom erular lesions in  
60 week-old MW F rats receiving lis in o p ril was even low er in  respect to 
tha t observed in  50 week-old rats, suggesting the a b ility  o f ACE in h ib ito r
75
CHAPTER 4: RESULTS
to induce regression o f glom erular in ju ry . A t 60 weeks, M W F rats had 
renal function  im pairm ent and developed hypertension (serum creatinine, 
2.0 + 0.3 versus controls: 0.7 + 0.01 m g / dL, systolic blood pressure: 192.0 +
5.2 versus controls: 127.0 + 1.7 m m  Hg, P < 0.01). Treatm ent w ith  ACE 
in h ib ito r (from  50 to 60 weeks o f age) decreased serum creatinine levels 
(1.3 + 0.1 m g / dL, P < 0.05) and systolic blood pressure (133.0 + 16.8 m m  
H g, P < 0.05) w ith  respect to rats receiving saline.
W hen animals were treated on ly  2 weeks w ith  ACE in h ib ito r, from  
50 to 52 weeks of age, pro te inuria  was on ly m ild ly  affected, and the index 
o f crescents d id  no t change (50 week old: 1.5 + 0.2 versus treated 52 week 
old: 1.6+ 0.3).
4.6 ACE in h ib ito r lim ite d  ce ll p ro life ra tio n  in  crescents
To investigate whether the renoprotection exerted by ACE in h ib ito r 
occurs v ia  the lim ita tio n  o f cell p ro life ra tion  in  crescents, we evaluated the 
num ber o f B rdU -retain ing cells in  pulsed MW F animals at 60 weeks o f 
age, receiving or no t lis in o p ril (Figure 7A). The num ber o f B rdU + 
p ro life ra ting  cells in  crescentic lesions o f MW F rats given saline accounted 
fo r 9.6% + 1.5%. The m ajority o f BrdU-labeled cells expressed c la u d in l in  
the absence o f podocyte m arker WT1, whereas p ro life ra tin g  
c la u d in l+W T l+ represented a m inor cell popula tion in  crescents. F ina lly , 
d iffe rentia ted podocytes expressing WT1 in  the absence o f c la u d in l
76
CHAPTER 4: RESULTS
markers were alm ost absent (Figure 7B and C). Ten week treatm ent w ith  
ACE in h ib ito r s ign ifican tly  decreased the p ro life ra tion  o f a ll cell 
populations in  respect to MW F rats receiving saline (Figure 7B).
That c la u d in l+ cells w ith in  the crescents represent a popula tion o f 
progenitor cells was confirm ed by im m unostaining fo r N C A M  (Figure 8). 
Consistently w ith  the decreased p ro life ra tion  o f c la u d in l+W TT and 
c la u d in l+W T1+ cells, treatm ent w ith  ACE in h ib ito r effectively reduced the 
presence o f N C A M + cells in  crescents by lim itin g  progenitor cell activation 
and m igration tow ard cap illa ry tu ft. O f note, fo llo w in g  the treatm ent w ith  
lis in o p ril, the d is tribu tion  o f progenitor cells along die Bowman's capsule 
was restored to  a pattern s im ila r to controls (Figure 8C versus A).
4.7 ACE in h ib ito r preserved Bowm an's capsule architecture
The antip ro life ra tive  effect o f ACE in h ib ito r on c la u d in l+ cells 
constitu ting the crescents, prom pted us to analyze whether th is d rug can 
also influence the p ro life ra tive  status o f c la u d in l+ cells in  the Bowman's 
capsule. In  line  w ith  data obtained few  years ago by a group of our 
Institu te  (Macconi et al., 2009), the to ta l num ber o f PECs lin in g  the 
Bowman's capsule was comparable in  60-week-old MW F rats (445.8 + 19.8 
x 10A/p m  o f capsule) and controls (427.2 + 5.2 x 10A/  pm of capsule). The 
characterization o f cell phenotype demonstrated that, as compared w ith
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controls, in  untreated 60-week-old MW F rats the percentage o f 
c la u d in l+ W T l- PECs was m arkedly enhanced at the expense o f 
c la u d in l+W T l+ parie ta l podocytes tha t s ign ifican tly  decreased (Figure 
9A). The p ro life ra tive  status o f c la u d in l+ PECs in  the Bowman's capsule o f 
MW F rats, as assessed by the quantifica tion  o f B rdU -reta in ing cells, was 
m arkedly enhanced as compared w ith  controls, in  w h ich p ro life ra ting  
c la u d in l+ PECs were extrem ely rare (Figure 9B and C).
Consistent w ith  the a b ility  o f ACE in h ib ito r to reduce p ro life ra tion  o f 
c la u d in l+ cells in  crescents, the treatm ent w ith  lis in o p ril also reduced the 
p ro life ra tive  status of Bowman's capsule cells (Figure 9B). The effect o f 
ACE in h ib ito r in  lim itin g  cell p ro life ra tion  paralleled the restoration o f the 
ra tio  between c la u d in l+ PECs and parie ta l podocytes (c la u d in l+W T l+) in  
the Bowman's capsule (Figure 9A).
4.8 M echanism  u n d e rly in g  the renoprotective e ffect o f ACE in h ib ito r:
4.8.1 Role o f the tran scrip tion  facto r C/EBP6
To deepen the mechanism by w h ich  ACE in h ib ito r lim its  the 
abnorm al p ro life ra tion  o f c la u d in l+ progenitor cells, we evaluated the role 
o f C/EBPS, a transcrip tion factor specific fo r adu lt cells and m ito tica lly  
quiescent stem cells o f ep ithe lia l o rig in  (Barbaro et al., 2007), w h ich  
regulates cell cycle and selfrenewal po ten tia l (O 'Rourke et ah, 1997, Zhang
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et at, 2008). In  W istar rats, C/EBP5 was detectable in  the m ajority o f cell 
nucle i along the Bowman's capsule, ind ica ting  the low -cycling status o f 
these cells, whereas it  was m arkedly decreased in  untreated 60 week-old 
MW F rats. ACE in h ib ito r restored C/EBP5 expression to contro l levels 
(Figure 10), suggesting the involvem ent o f C/EBP5 in  the an tip ro life ra tive  
effect o f th is drug.
4.8.2 Role o f the chem okine receptor CXCR4
To evaluate the potentia l role o f chemokines in  prom oting cell 
p ro life ra tion  resu lting in  the form ation o f crescentic lesions, we analyzed 
the expression o f SDF-1 and its  receptor CXCR4 in  60 week-old MW F rats, 
treated or no t w ith  ACE in h ib ito r. W hile in  W istar rats SDF-1 was rare ly 
detectable in  few  cells along the Bowman's capsule, its  expression 
m arkedly increased in  MW F rats specifically in  podocytes, as documented 
by double im m unostaining w ith  nephrin (Figure 11 A , arrows). O f note, 
SDF-1 staining showed no co-localization w ith  E D I macrophages (Figure 
11B). The enhanced SDF-1 expression in  MW F rats paralleled an increase 
of its  receptor CXCR4, w h ich in  60 week-old animals was m ain ly localized 
in  the area o f hyperplastic lesions (Figure 11C, inset). MW F rats receiving 
ACE in h ib ito r treatm ent showed a norm alization o f the im m unostaining 
fo r both SDF-1 and CXCR4 (Figure 11A and C) and no more abundance of 
E D I macrophages than in  the norm al kidney (Figure 11B).
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4.8.3 Role o f A T i receptor
G iven the an tip ro life ra tive  effect o f ACE in h ib ito r on parie ta l 
ep ithe lia l cells, we w onder to evaluate the expression o f A T i receptor in  
W istar and M W F rats, treated or no t w ith  lis in o p ril. In  W istar rats A T i 
receptor was expressed by few  PECs along the Bowman's capsule (Figure 
12A). The enhanced cell p ro life ra tion  observed in  M W F rats was 
associated w ith  an increase in  A T i receptor expression, w h ich  localized in  
the glom erulus inc lud ing  the Bowman's capsule (Figure 12B, arrows), as 
w e ll as in  the area o f hyperplastic lesions (Figure 12B, arrowheads). The 
M W F rats given the ACE in h ib ito r lis in o p ril showed a sign ifican t 
reduction in  the num ber o f PECs expressing the A T i receptor compared 
w ith  untreated animals (Figure 12C vs B, arrows), suggesting a key ro le  o f 
the A T i receptor in  progenitor cell-m ediated extracapillary p ro life ra tion . 
A  quantifica tion o f PECs expressing A T i receptor was given in  Figure 
12D.
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4.9 In  vitro characterization o f PECs
Parietal ep ithe lia l cells were isolated by the in itia l outgrow th o f 
capsulated contro l ra t g lom eru li, as previously described (Sagrinati et al., 
2006, Swetha et al., 2009). Immunofluorescence analysis on cultured cells 
confirm ed data obtained ex vivo in  renal tissue, shown in  Figure 1. Isolated 
PECs expressed either m arkers o f adu lt ep ithe lia l cells such as claudin-1, 
or markers o f im m ature progenitors inc lud ing  N C AM , and CD24 (Figure 
13A). Im m unoisolated c la u d in l+ PECs can d ifferentiate and generate 
podocytes, as documented by the a b ility  to acquire the podocyte m arker 
synaptopodin when exposed to a specific inductive  m edium , named 
VRAD (Ronconi et al., 2009) (Figure 13B to D). A fte r 7 days exposure to 
VRAD, 29% o f cells acquired the specific podocyte m arker w ith  the typ ica l 
localization along cytoskeletal fibers (Figure 13C and D), according w ith  
the theory tha t PECs contain a popula tion o f progenitor cells devoted to 
generate podocytes.
To evaluate the capacity o f angiotensin I I  to induce PEC 
p ro life ra tion , we evaluated the phosphorylated fo rm  o f H istone H3-serine 
10 (H3p) as a m arker o f m itosis, on im m unoisolated c laud in l+  PECs, 
before and after 24 hour incubation w ith  Ang II. A fte r Ang I I  exposure, a 
large num ber o f PECs revealed nuclear-positive granular staining fo r H3p 
w ith  respect to unstim ulated cells (Figure 14B versus A). The percentage 
o f Ang II-induced p ro life ra ting  cells averaged 39% + 6% as compared to 
15% + 3% observed in  unstim ulated cells (Figure 14C).
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The involvem ent o f the transcrip tion factor C/EBPS in  the regulation 
o f PECs p ro life ra tion  was also assessed. In  line  w ith  the above data, 
incubation w ith  A ng I I  m arkedly reduced the expression o f C/EBPS 
(Figure 14D and E), suggesting tha t the m itogenic effect o f the peptide can 
be exerted through the dow n-regulation o f the C/EBPS signa lling 
pathway.
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IClaudinl
Figure 1. Populations of cells in the Bowman's capsule of normal rat kidney.
(A) Representative picture of immunofluorescence stainings of claudinl and WT1 
in the Bowman's capsule of Wistar rats used as controls. High-magnification insets 
show. claudinl+W Tl- cell (upper insets) and claudinl+W Tl+ cell (lower insets). 
Scale bars=25 pm (B) Representative pattern of immunogold labelling for nephrin 
in the Bowman's capsule of Wistar rats. Left panel shows the ultrastructure of 
parietal cells along the Bowman's capsule. High-magnification inset (right panel) 
shows that gold particles are localized along the foot processes of parietal cells. 
Original magnifications x4400 (left panel) and x71000 (right panel).
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Figure 2. Identification of three progenitor cell populations in the Bowman's capsule 
of normal rat kidney.
(A) Double-immunolabeling for claudinl and NCAM shows in most of die cells die 
colocalizadon of the two markers. (B) Double immunofluorescence staining for NCAM 
and CD24 reveals that in die Bowman's capsule die two antigen are expressed by the 
same cells. (C) Representative photomicrograph showing three distinct cell populations 
in the Bowman's capsule of Wistar rats, identified by staining of NCAM and WT1: 
NCAM+WT1- progenitor cells (upper inset), NCAM+WT1+ transitional cells (middle 
inset) and NCAM-WT1+ parietal podocytes (lower inset). DAPI stains nuclei. Scale 
bars=25 pm (D) Schematic representation of the cell populations identified in the 
Bowman's capsule of Wistar rats. All the cells were positive for PEC marker claudinl. 
A gradient of expression of NCAM and WT1 defined three populations of claudinl+ 
PECs with different degree of differentiation.
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A Index of synechiae 
Index o f crescents
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Figure 3. Time course of proteinuria and histologic glomerular lesions in 
Wistar and MWF rats.
(A) Age-related changes of the index of synechiae (striped bars), and crescents 
(dark grey bars) quantified in Wistar (n=20) and MWF (n=50) rats. ** P<0.01 vs 
lOw MWF; * P<0.05 vs lOw MWF; °P<0.01 vs 25w MWF; §P<0.01 vs 40w MWF; $ 
P<0.01 vs 50w MWF; f  P<0.01 vs 60w MWF. (B) Proteinuria levels progressively 
increased with age in MWF rats. ** P<0.01 vs lOw MWF; °P<0.01 vs 25w MWF; 
§P<0.01 vs 40w MWF; $ P<0.01 vs 50w MWF; f  P<0.01 vs 60w MWF.
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Figure 4. T im e-dependent evolution of glomerular lesions in  Wistar and  
MWF rats.
Upper panels show that renal sections of 60 week-old Wistar rats are 
characterized by few synechiae. In MWF rats, synechiae were present from 10 
weeks of age, and more severe crescentic lesions develop from 25 weeks of age 
and progressively increased with time. Lower panels show representative 
pictures of type III collagen immunostaining. Synechiae in Wistar rats are not 
associated with accumulation of type III collagen. Also early crescents found 
in 25 week-old MWF rats, are negative for type III collagen. In 40 week-old 
MWF rats, crescents are characterized by scanty accumulation of type III 
collagen, which progressively increased with time. Scale bars=25 pm
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Figure 5. Phenotype of cell populations involved  in  crescentic lesions.
(A) Representative pictures of immunofluorescence stainings for 
claudinl, WTl, T hyl.l and EDI in glomeruli of 60 week-old MWF rats. 
High magnification insets show cells positive for the different markers. 
Dotted lines define the area of crescents in which positive cells have 
been quantified. DAPI stains nuclei. Scale bars=25 pm (B) Quantitative 
assessment of cells positive for each marker, reveals that the most 
represented cell population in crescents consists of claudinl + cells, and 
to a lesser extent of WT1+ cells. Thyl.l+ and ED1+ cells represented 
minor cell populations within the lesions.
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Figure 6. ACE inhibitor lowers proteinuria levels and reduces the 
number and extension of crescents.
A significant decrease of proteinuria levels and index of crescents 
was observed in 60 week-old MWF rats receiving ACEi for 10 weeks 
as compared with animals given saline. * P<0.01 vs 60w MWF.
CHAPTER 4: RESULTS
A BrdU (4days)
50w 60wOw
BrdU (4days)
50w 60wOw
Lisinopril
B . r v
. / K '  '  ' '
,5% v *  , >* «■ I'.
t
.v
Claudinl WTL BrdU -  —
B
3 6- 
b
C/j
13 4*
rai 2 u
0
□  % Claudinl+WTl-BrdU+ cells
□  % Claudinl+WTl+Brd U + cells 
■  % Claudinl-WTl+BrdU+ cells
Saline ACEi
MWF 60w
Figure 7. ACE inhibitor limits progenitor cell proliferation and migration.
(A) Experimental design. Rats receiving or not lisinopril for 10 weeks, were injected with 
BrdU 4 days before sacrifice. (B) The percentage of BrdU+ claudinl+WTl- cells (white 
bars), claudinl+W Tl+ cells (grey bars), and claudinl-WT1+ cells (black bars), was lower 
in crescents of ACEi-treated MWF rats in respect with animals given saline. **P<0.05 vs 
60w MWF; *P<0.01 vs 60w MWF. (C) Representative picture of immunofluorescence 
staining for claudinl (red), WTl (green) and BrdU (white) in 60 week-old MWF rats. 
DAPI stains nuclei. Scale bar=25 um
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Figure 8. ACE inhibitor limits progenitor cell proliferation and migration.
(A) In Wistar rats, NCAM+ cells were localized along the Bowman's capsule. (B) The 
expression of NCAM increases in glomeruli of 60 week-old MWF rats and localizes in 
the capillary tuft as well as in crescents. (C) ACEi effectively reduced the presence of 
NCAM+ cells in crescents and restored the distribution of NCAM+ cells in the 
Bowman's capsule as to the pattern observed in controls. DAPI stains nuclei. Scale 
bars=25 pm
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Figure 9. ACE inhibitor reduces proliferation of Bowman's capsule cells.
(A) In the Bowman's capsule of 60 week-old MWF rats given saline, the 
percentage of claudinl+WTl- cells is markedly enhanced and 
claudinl+WTl+ cells is decreased in respect to Wistar rats. ACEi restores 
the percentage of both cell populations to control levels. (B) Cell 
proliferation of claudinl+ cells along the Bowman's capsule is enhanced in 
60 week-old MWF rats given saline as compared with controls. ACEi 
treatment significantly limits the number of proliferating cells within the 
Bowman's capsule (claudinl+BrdU+). *P<0.05 vs Wistar; **P<0.01 vs 60w 
MWF+saline. (C) Representative picture of immunofluorescence staining for 
claudinl and BrdU in the Bowman's capsule of 60 week-old MWF rats. Inset 
shows a cell expressing both markers. DAPI stains nuclei. Scale bar=25 pm
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Figure 10. ACE inhibitor regulates the expression of the cell-cycle 
inhibitor CyEBP5.
Histogram shows that the expression of C/EBP5 in the Bowman's capsule 
decreases in MWF rats at 60 weeks of age receiving saline as compared 
with Wistar rats, and was normalized by ACEi treatment. *P<0.05 vs 
Wistar; ***P<0.05 vs 60w MWF+saline. In the lower panels and in high- 
magnification insets, representative pictures show the expression of 
C/EBP8 in the rat Bowman's capsule. Nuclei were counterstained with 
hematoxylin. Scale bars=25 pm
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Figure 11. SDF-1 and CXCR4 expression in Wistar and MWF rats
(A) SDF-1 was up-regulated in MWF rats in respect with controls, and co­
localized with nephrin (arrows highlighted the double labelled 
podocytes). ACE inhibitor restored the expression of SDF-1 to control 
levels. (B) Representative photomicrographs of double immunostaining 
for SDF-1 and EDI showing that the markers did not overlapped. (C) 
CXCR4 was markedly overexpressed by cells within hyperplastic lesions 
(inset) in the MWF rat glomerulus. ACE inhibitor treatment normalized 
the expression of CXCR4 to a level comparable with controls. DAPI (blue) 
stained nuclei, and renal structures were labelled with fluorescein wheat 
germ agglutinin (green). Scale bars=25 pm.
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Figure 12. ATj receptor expression in PECs of Wistar and MWF rats
(A) In Wistar rats used as control, few cells in the Bowman's capsule 
expressed the AT^ receptor (arrow). (B) In MWF rats given saline, the ATj 
receptor was expressed by the majority of parietal epithelial cells (arrows) 
as well as by cells within hyperplastic lesions (arrowheads) (C) ACE 
inhibitor treatment reduces the expression of the AT1 receptor on PECs 
(arrows). DAPI (blue) stained nuclei, and renal structures were labelled 
with rhodamine lens culinaris agglutinin (red). Scale bars=25 pm. (D) 
Histogram showing that the num ber of ATa receptor+ cells along the 
Bowman's capsule was significantly higher in MWF rats given saline as 
compared with controls. A T 1 receptor over-expression on PECs was 
reduced by ACE inhibitor treatment. 00 P<0.01 vs Wistar rats, ** P<0.01 vs 
MWF rats given saline.
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Figure 13. Characterization and differentiation of cultured PECs.
(A) Isolated PECs constitutively expressed claudinl, NCAM or CD24. (B- 
C) Representative micrographs of immunoisolated claudinl + PECs stained 
with synaptopodin (SYN). No signal for SYN (B) was observed in control 
cells while cells exposed to VRAD medium for 7 days expressed the 
podocyte marker SYN (C). DAPI stains nuclei. Original magnification x630. 
(D) Quantification of the percentage of SYN+ cells in each HPF *P<0.001 vs 
Control.
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Figure 14. Characterization and differentiation of cultured PECs.
(A-B) Representative images of H3p and DAPI in immunoisolated claudinl+ 
PECs untreated (A) or treated (B) with angiotensin II (Ang II) for 24 hours. (I) 
Quantification of H3p+ cells per each HPF shows that mitotic cells markedly 
increases when exposed to Ang II in respect to untreated cells. DAPI stains 
nuclei. *P<0.001 vs control. (D-E) Nuclear PECs show a constitutive nuclear 
expression of the transcription factor C/EBPS (E), that was markedly reduced 
after 6 hour-incubation with Ang II (F). Original magnification x630.
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5.1 In trodu c tion
Crescentic lesions containing m ultilayers o f cells in  the glom erular 
Bowman's space, are sign o f po ten tia lly  severe in ju ry  responsible fo r 
evo lu tion  to glom erular scarring and chronic renal fa ilu re . The m ost 
ha rm fu l and diffuse crescentic lesions are found in  kidneys o f patients 
w ith  in flam m atory g lom erular diseases, typ ica lly  crescentic 
g lom erulonephritis, b u t also other p ro life ra tive  form s in c lud ing  lupus 
nephritis, IgA  nephropathy, and m em branoproliferative 
glom erulonephritis (Kambham et al., 2012; Jennette et al., 2003).
A lthough extracapillary lesions are m orphologica lly sim ple to  be 
recognized, more controversial have been studying the ir ce llu lar 
components and the ir possible pathogenic role. The tra d itio n a l theories 
have come large ly from  im m unohistochem ical studies tha t have 
concluded tha t m ultilayered ce llu lar lesions are a m ixture  o f glom erular 
parie ta l ep ithe lia l cells, macrophages and m yofibroblasts (Boucher et al., 
1987, N itta  et al., 1999, Jennette et ah, 1986). M ore recent studies also 
suggested the podocytes as key constituents o f the crescents (M oeller et al., 
2004, Bariety et al., 2005, D ing  et al., 2006, Thorner et al., 2008), b u t the ir 
role remains unclear. Recently, i t  has been suggested tha t these 
extracapillary lesions can be the resu lt o f dysregulated p ro life ra tion  o f 
renal progenitor cells in  response to the in ju red  podocytes (Smeets et al.,
2009). Nevertheless, the mechanisms and m ediators responsible fo r the 
in trag lom eru lar accum ulation o f renal progenitor cells in  p ro life ra tive
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glom erulonephritis rem ain ill-de fined . Evidence in  SCID mice w ith  acute 
renal fa ilu re  indicates an im portan t role o f SDF-1 and its  receptor CXCR4 
in  the therapeutic m igra tion o f renal progenitor cells (M azzinghi et al, 
2008). Since activation o f the Ang I I /  A T i receptor pathw ay m ay contribute 
to cell p ro life ra tion  and m igra tion  (K im  et al., 2011), we have reasoned that 
the A T i receptor can also p lay a key role in  the abnorm al p ro life ra tion  of 
renal progenitors underly ing  the hyperplastic lesions.
Therefore, we have got fu rthe r insights in to  the ce llu lar mechanisms 
and m ediators contribu ting to extracapillary p ro life ra tion  in  humans, by 
analyzing the contribu tion o f the SDF1/CXCR4 axis and Ang II/A T i 
receptor pathw ay to the m igra tion  and p ro life ra tion  o f renal progenitors, 
resu lting in  the progression o f extracapillary lesions.
5.2 C lin ica l and h istopatho log ic characteristics o f pa tien t popula tions
Table 2 showed the clin ica l and histopathological characteristics of 
patients whose renal biopsies have been processed and studied. Four 
diagnostic groups have been considered inc lud ing  extracapillary 
g lom erulonephritis (n=9), IgA  nephropathy (n=9), membranous 
nephropathy (n=7) and diabetic nephropathy (n = ll) .
The baseline characteristics at the tim e o f biopsy were s im ila r among 
the d iffe ren t groups. The mean age o f the study subjects was 53 years, and 
there was a s ligh t male predominance, except fo r patients w ith
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extracapillary glom erulonephritis. There were no differences in  baseline 
systolic and diasto lic blood pressure when com paring a ll the patients, 
w h ile  p ro te inuria  and serum creatinine were s ligh tly  low er in  patients 
w ith  Ig A  nephropathy in  respect to the other diagnostic groups.
On the basis o f renal h isto logy, glom erular diseases were d iv ided  
in to  p ro life ra tive  and non p ro life ra tive  pathologies. For each group, the 
histopathological characteristics in c lud ing  the percentage o f p a rtia lly  and 
to ta lly  sclerotic g lom eru li, and o f g lom eru li w ith  some degree o f 
extracapillary p ro life ra tion  were reported. As shown in  table 2, biopsies o f 
patients w ith  extracapillary g lom erulonephritis, and at m inor extent those 
w ith  IgA  nephropathy, were characterized by an h igh percentage o f 
g lom eru li w ith  extracapillary p ro life ra tion . On the contrary, the 
extracapillary p ro life ra tion  was absent in  biopsies o f patients w ith  
membranous and diabetic nephropathy. The percentage o f g lom eru li w ith  
global or segmental sclerosis was comparable among a ll the diagnostic 
groups, w h ile  the num ber o f g lom eru li w ith  other glom erular lesions, 
apart o f crescents and sclerosis, was higher in  biopsies o f patients w ith  
non p ro life ra tive  diseases in  respect to patients w ith  extracapilla ry 
glom erulonephritis and IgA  nephropathy.
Renal biopsies from  un invo lved po rtion  o f kidney collected fo r 
tum or nephrectom y obtained from  10 patients were used as controls.
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5.3 CD133+CD24+ renal p rogen ito r cells were m ajor constituents o f
hyperp lastic lesions
According to our previous study (Smeets et at, 2009), crescentic 
lesions found in  biopsies o f patients w ith  extracapillary 
glom erulonephritis were m ostly constituted by CD133+CD24+ cells (Figure 
15A). To investigate whether m igra tion  and accum ulation o f progenitor 
cells occurs in  renal diseases characterized by active cell p ro life ra tion , we 
also analyzed biopsies o f patients w ith  IgA  nephropathy, in  w hich 
abundant CD133+CD24+ cells was consistently found in  a ll segmental 
lesions between the Bowman's capsule and the glom erular cap illa ry tu ft 
(Figure 15B). To assess whether exuberant progenitor cell accum ulation 
was confined to p ro life ra tive  disorders, we next evaluated CD133 and 
CD24 staining in  biopsies from  patients w ith  membranous nephropathy 
(Figure 15C) and diabetic nephropathy (Figure 15D). In  these la tter 
settings, progenitor cells d id  not d isplay any sign o f m igra tion and were 
found in  the Bowman's capsule, in  a m anner sim ilar to controls (Figure 
15E).
5.4 CXCR4 was overexpressed in  p rogen ito r cells w ith in  extracapilla ry
lesions
A  recent in vitro study documents the expression o f the chemokine 
receptor CXCR4 in  hum an renal progenitor cells, w h ich is related to  the
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m igra tory p roperty o f these cells (M azzinghi et al., 2008). Here we 
evaluated the localization of CXCR4 in  biopsies o f patients w ith  
p ro life ra tive  glom erulonephritis and non p ro life ra tive  glom erular 
disorders. In  both extracapillary g lom erulonephritis and IgA  
nephropathy, a h igh  CXCR4 expression was observed, w h ich  co-localized 
w ith  CD24 progenitor m arker w ith in  hyperplastic lesions (Figure 16A).
On the contrary, in  biopsies from  patients w ith  non p ro life ra tive  
disorders such as membranous nephropathy or diabetes (Figure 16B and 
C), the expression o f CXCR4 was fa in t and i t  was restricted to  a few  CD24+ 
progenitor cells along the Bowman's capsule, as a pattern s im ila r to  those 
observed in  g lom eru li from  norm al kidneys (Figure 16D).
5.5 Podocytes expressed the CXCR4 ligan d  SDF-1
The increased expression o f CXCR4 by renal progenitor cells 
observed in  patients w ith  p ro life ra tive  disorders in  respect to controls, 
paralleled a s ign ificant increase o f the CXCR4 ligand SDF-1 (Fig 17A and 
B). Sem i-quantitative evaluation o f SDF-1 im m unostain ing revealed tha t 
the difference was statistically s ign ifican t (Figure 17C, P<0.05). A  
phenotypic characterization o f SDF-l-expressing cells by double 
im m unolabelings revealed that podocytes w ith in  the glom erular tu ft 
expressed SDF-1, suggesting that they can presum ably provide the ligand  
fo r CXCR4 in  patients w ith  p ro life ra tive  g lom erulonephritis (Figure 17A).
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SDF-1 was also expressed by few  PECs, at a comparable extent in  
p ro life ra tive  diseases and in  controls (Figure 17A  and B). On the contrast, 
CD68+ macrophages, w h ich in filtra te d  the hyperplastic lesions, were no t 
the cellu lar source o f SDF-1 (Figure 17D) as documented by the absence of 
co-localization between the tw o markers.
5.6 A T i receptor overexpression on progen ito r cells in  hum an 
p ro life ra tive  disorders
G iven the po tentia l role o f Ang I I /  A T i receptor pathw ay to favour 
cell p ro life ra tion  and m igration (K im  et al., 2011), we then analyzed the 
localization o f A T i receptor in  p ro life ra tive  disorders. In  both patients 
w ith  extracapillary g lom erulonephritis and IgA  nephropathy, A T i 
receptor was abundantly expressed by cells along the Bowman's capsule 
as w e ll as w ith in  ce llu lar synechiae, the early m orphological abnorm alities 
preceding extracapillary lesion form ation (Figure 18A, arrows). That A T i 
receptor-expressing cells were progenitors, was documented by double 
im m unofluorescence staining w ith  tire progenitor cell m arker CD24 
(Figure 18B). As shown in  the inset in  Figure 18B, in  patients w ith  
p ro life ra tive  diseases A T i receptor expression was m aintained by 
progenitor cells fo rm ing  crescentic lesions. This was no t the case in  b iop tic 
tissues from  patients w ith  non pro life ra tive  disorders (Figure 18C) and in  
norm al k idney (Figure 18D), where A T i receptor expression was only
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restricted to few  progenitor cells in  the Bowman's capsule (Figure 18C and 
D, arrows), as also documented by co-localization o f the A T i receptor w ith  
CD24 (inset in  Figure 18E).
5.7 ACE in h ib ito r therapy lim ite d  the fo rm a tion  o f crescentic lesions in  
a pa tien t w ith  extracap illa ry g lom eru lonephritis
To provide evidence tha t up-regu la tion o f A T i receptor contributes 
to the form ation of glom erular hyperplastic lesions, we took advantage o f 
the case o f a 69 year-old patient w ith  A N C A -positive  crescentic 
g lom erulonephritis (already included in  the cohort o f patients studied 
here) w ho underw ent a repeated renal biopsy after 8 m onth treatm ent 
w ith  an ACE in h ib ito r (Figure 19A). A t the tim e o f the firs t biopsy, 73.7% 
glom eru li were affected by flo r id  extracapillary p ro life ra tion , w h ile  the 
rem nant g lom eru li were to ta lly  sclerotic and no one glom erulus was in tact 
and free of lesions (Figure 19B and C). Because o f h igh  p ro te inuria  (2.60 
g / day) and severe renal insuffic iency (serum creatinine 6.99 m g / d l), the 
patient received standard im m unosuppressive therapy w ith  steroids and 
cyclophosphamide. A fte r 7 m onth treatm ent, p ro te inuria  worsened (3.70 
g / day) despite m ild  am elioration o f renal function  (serum creatinine 4.37 
m g /d l, Figure 19A). Thus, the therapy was m odified  and increasing doses 
o f the ACE in h ib ito r ra m ip ril (from  2.5 to 7.5 m g / day) in  association w ith  
azathioprine were started (Figure 19A). E ight m onths later, both
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prote inuria  and serum creatinine levels were m arkedly reduced to 1.34 
g /d a y  and 1.74 m g /d l respectively (Figure 19A). A t th is tim e, a second 
biopsy revealed that a ll g lom eru li in  the tissue specimen were to ta lly  free 
o f crescents, suggesting the rem ission o f crescentic lesions observed in  the 
firs t biopsy (Figure 19B, C and D). O vera ll 38.5% o f g lom eru li were 
norm al, w h ile  46.1% showed global sclerosis.
5.8 ACE in h ib ito r renoprotection occurred v ia  the restoration o f CXCR4
and A T i receptor expression
Double im m unostaining o f the firs t biopsy revealed that the A T i 
receptor was h igh ly  expressed and co-localized on CD24+ progenitor cells 
in  the area o f hyperplasia (Figure 20A). In  the repeated biopsy after ACE 
in h ib ito r treatm ent, A T i receptor staining was m arkedly reduced on 
CD24+ progenitor cells (Figure 20B), w h ich were no longer present w ith in  
the extracapillary space, b u t on ly localized along the Bowman's capsule, 
as previously documented in  patients w ith  non p ro life ra tive  diseases as 
w e ll as in  norm al kidneys (Figure 15C, D and E).
The decrease o f A T i receptor after ACE in h ib ito r paralleled a strong 
reduction o f CXCR4 expression, w h ich in  the firs t b iopsy co-localized w ith  
the progenitor cell m arker CD24 in  the m ajority o f cells in  crescentic 
lesions (Figure 20C), w h ile  after ACE in h ib ito r treatm ent was only fa in tly  
expressed (Figure 20D). O f note, CXCR4 im m unostaining after
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pharm acological treatm ent was comparable to tha t p reviously observed in  
patients w ith  non p ro life ra tive  nephropathies and in  the norm al kidney 
(Figure 16B, C and D).
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Proliferative Non proliferative
Extracapillary IgA 
Glomerulonephritis Nephropathy
Membranous Diabetic 
Nephropathy Nephropathy
Patients (n) 9 9 7 11
Age (years-range) 32-81 32-50 44-66 54-70
Sex (M;F) 3:6 7:1 4:3 9:1
SBP (mmHg) 135.6±4.7 126.0±8.1 136.8±4.7 145.8±5.4
DBP (mmHg) 80.0±1 ,78 78.8±5.3 80.8±0 .8 85.0±2.1
Proteinuria (g/day) 5 .6±1.4 1.2±0.2 5 .6±1.3 4.1±0.6
Serum creatinine (mg/dl) 3 .9±0.9 1.8±0.6 2 .5±0.6 1.2±0.2
Glomeruli with extracapillary proliferation (% ) 60.9±8.6 15.0±5.8 0.0±0.0 0.4±0.0
Normal glomeruli (% ) 9 .4±5 .5 16.1±5.6 17.9±4.3 30±7.2
Glomeruli with global sclerosis (% ) 17.5±4.3 32.8±9.2 14.8±7.9 15.0±3.8
Glomeruli with segmental sclerosis (% ) 4 .4±3.0 14.4±3.4 1.9±1.9 27.2±10.2
Other glomerular changes (% )* 21.8±4.2 28.2±4.2 71.4±4.5 49.5±6.4
*  capillary loop thickening, mesangial hypercellularity and matrix expansion, epithelial vacuolization
Table 2. Demographic, clinical and histopathologic characteristics of patient populations.
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Figure 15. CD24-CD133 expression in patients w ith proliferative and non 
proliferative disorders.
Double immunofluorescence staining fo r CD24 and CD133 revealed that in  
glom eruli o f patients w ith  extracapillary glom erulonephritis (A) and IgA  
nephropathy (B) the two antigens co-localized inside crescentic lesions. In 
membranous nephropathy (C) and in  diabetic nephopathy (D) 
CD24+CD133+ cells were confined to the Bowman's capsule as observed in  
norm al control kidneys (E). Scale bars=50 pm.
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Proliferative diseases
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Figure 16. CXCR4 was expressed by CD24+ progenitor cells.
(A) In patients with extracapillary glomerulonephritis, CXCR4 
was expressed by the majority of CD24+ progenitor cells 
within hyperplastic lesions, (insets). In patients with 
membranous (B) and diabetic (C) nephropathies, CXCR4 
expression was faint and no cells in the Bowman's capsule co­
expressed the CD24 progenitor marker. (D) In normal human 
glomeruli few CD24+ cells in the Bowman's capsule also 
expressed CXCR4 (insets). DAPI (blue) stained nuclei. Scale 
bars=50 pm and 25 pm for enlargements.
109
CHAPTER 5: RESULTS
Proliferative diseases Normal kidney
a Proliferative diseases Normal kidney
Proliferative diseases
D
■' , i"
m i  .  0 4
f  .
-• * j y  * ^ * V 4
* ; >
SDF-1 CD68
Figure 17. SDF-1 overexpression in proliferative glomerulonephritides.
Representative pictures showing SDF-1 and nephrin co-localization in 
patients with extracapillary glomerulonephritis (A) and in control hum an 
glomeruli (B). (C) Histogram showing that SDF-1 expression was 
significantly increased in glomeruli of patients with extracapillary 
glomerulonephritis as compared with normal kidneys. * P<0.05 vs normal 
kidneys. (D) Double immunofluorescence staining of SDF-1 and CD68 
showed absence of co-localization between the two antigens. DAPI (blue) 
stained nuclei. Scale bars=50 pm.
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Figure 18. AT1 receptor expression was up-regulated in proliferative diseases.
In patients with extracapillary glomerulonephritis, cells in die area of hyperplasia 
expressed the ATt receptor (arrows) and co-localized with progenitor cell marker 
CD24 (B, insets). Representative photomicrographs of immunoperoxidase staining 
in non proliferative diseases (C) and in a normal human glomerulus (D) showing 
ATX receptor expression in a few parietal cells of the Bowman's capsule (arrows). 
(E) Co-localization of ATj receptor and CD24 expression showed that in normal 
human kidneys, the few parietal epithelial cells expressing the AT  ^receptor were 
progenitor cells (insets). DAPI (blue) stained nuclei. Scale bars=50 pm.
Non proliferative diseases Normal kidney
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Figure 19. ACE inhibitor therapy ameliorated renal function and morphology in a 
patient with extracapillary glomerulonephritis.
(A) Study design and clinical findings of a patient with severe ANCA-positive crescentic 
glomerulonephritis, who underwent renal biopsies before and after ACE inhibitor 
treatment. (B) Histogram reporting the percentage of glomeruli with different kinds of 
glomerular lesions observed in renal biopsies obtained before and after ACE inhibitor 
treatment. (C) PAS-stained biopsy of the patient before ACE inhibitor treatment revealed 
that the majority of glomeruli were affected by extracapillary proliferation. A 
representative photomicrograph showing a glomerulus with extracapillary proliferation 
is illustrated in the high-magnification inset. (D) After ACE inhibitor treatment, all 
glomeruli of the biopsy were totally free of crescentic lesions, as shown in the 
representative glomerulus in the high-magnification inset. Scale bars=100 pm.
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Biopsy I Biopsy il
Figure 20. ACE inhibitor therapy limited progenitor cell migration 
together with normalization of ATj receptor and CXCR4 
expression in a patient with extracapillary glomerulonephritis.
(A) In patient before ACE inhibitor treatment, ATt receptor was 
overexpressed in CD24+ progenitor cells in the area of hyperplasia 
(arrows). Scale bar=20 pm. (B) Following ACE inhibitor therapy, 
Al^ receptor expression was faint and no cells in the Bowmans 
capsule co-expressed the CD24 progenitor marker. (C-D) Double 
immunostaining for CXCR4 and CD24 showed that, while before 
ACE inhibitor treatment CXCR4 was expressed by CD24+ progenitor 
cells in crescents, following the treatment the expression of CXCR4 
was strongly reduced. Scale bars=50 pm.
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In  the last years, increasing interest is aroused in  determ ining the 
pathogenetic role o f renal progenitor cells, tha t are populations o f cells 
w ith  sternness properties w h ich  in  physio logica l conditions reside in  
niches located in  d iffe ren t portions o f the adu lt kidney. Am ong resident 
renal progenitors, i t  has been dem onstrated tha t a subset o f PECs 
expressing CD133 and CD24 stem cell markers, norm a lly  ly in g  in  the 
Bowman's capsule o f healthy hum an g lom eru li, contribute to the 
form ation o f hyperplastic lesions in  patients w ith  d iffe ren t 
podocytopathies (Smeets et ah, 2009).
Here we confirm ed tha t CD133+CD24+ renal progenitor cells 
pro life ra te and accumulate in to  the m ultilayered crescentic lesions in  
patients w ith  glom erulonephritides characterized by extracapilla ry 
p ro life ra tion , in c lud ing  extracapillary g lom erulonephritis and IgA  
nephropathy. M oreover, we have provided evidence tha t the dysregulated 
p ro life ra tion  o f CD133+CD24+ progenitor cells is a prom inent feature o f 
glom erulonephritides w ith  extracapillary profera tion, b u t no t o f 
membranous nor diabetic nephropathies, in  w h ich  progenitor cells line  the 
inner surface o f the Bowman's capsule in  a manner s im ila r to hea lthy 
hum an glom eruli.
A  s im ila r progenitor cell popula tion has been here iden tified  fo r the 
firs t tim e in  ra t tissue. In  search o f a m arker o f sternness in  rats, we have 
focused on N C AM , norm ally expressed in  rodent and hum an m etanephric 
mesenchyme, and in  the Bowman's capsule o f the m ature ra t k idney
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(Abbate et at, 1999; Bard et at, 2001). Here, we show that N C AM  is 
expressed by the large m ajority o f c la u d in l+ PECs in  the Bowman's 
capsule, and tha t N C A M + cells coexpress CD24, a m arker of sternness in  
hum an and mouse kidneys. M oreover, fin d in g  tha t cultured PECs 
expressing c la u d in l and N C AM , when exposed to  an appropriate 
inductive m edium  can acquire phenotypic features o f differentiated 
podocytes, fu rthe r supports the no tion  tha t N C A M + cells represent a 
progenitor cell popula tion in  rats. In  agreement w ith  previous find ings in  
humans (Ronconi et at, 2009), co-staining w ith  N C A M  and the podocyte 
m arker WT1 allow ed to id e n tify  three d is tinct ce ll populations of 
ep ithe lia l o rig in  in  the Bowman's capsule o f norm al rats: im m ature 
progenitor cells expressing only N C A M  in  absence o f podocyte m arker 
WT1, transitiona l cells expressing markers fo r both progenitor cells and 
podocytes (N C A M +W T1+), and more d ifferentiated ep ithe lia l cells, the 
parie ta l podocytes (NCAM 'W T1+).
In  para lle l w ith  observation in  hum an pro life ra tive  diseases, we 
investigate the contribu tion  o f renal progenitor cells during  the evolution 
o f glom erular lesions in  rats. We have taken advantage o f a m odel o f 
progressive nephropathy characterized by h igh protenuria and 
glomerulosclerosis, the MW F rats, in  w h ich we have previously 
demonstrated the effect o f ACE in h ib ito r in  reducing glom erular lesions 
and in  regenerating new capillary tu fts  (Remuzzi A  et at, 2006). Here, by 
studying MW F rats at d iffe ren t weeks o f age, the early abnorm alities seen
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in  young rats were bridges between parie ta l and visceral epithelium , 
named synechiae, fo llow ed  by extracapillary crescentic lesions and 
glomerulosclerosis la ter on. A ccord ing ly w ith  find ings in  hum an biopsies, 
the m a jo rity  o f cells in  crescents are parie ta l ep ithe lia l cells o f the 
Bowman's capsule (c la u d in l+ PECs), whereas podocytes are present at a 
low er extent. C la u d in l+ PECs w ith in  crescents pro life ra te , as 
dem onstrated by the presence o f B rdU -reta in ing cells in  pulsed animals.
Evidence are available tha t PECs o f the Bowm an's capsule 
represent a reservoir o f cells tha t contribute to  podocyte physio logica l 
tu rnover (Ronconi et ah, 2009). The norm al ra tio  between c la u d in l+ PECs 
and parie ta l podocytes in  contro l rats is altered in  o ld  M W F animals, in  
w h ich  c la u d in l+ PECs increase in  num ber at the expense o f parie ta l 
podocytes and they actively pro life ra te, reflecting dysregulation o f the ir 
a b ility  to generate podocytes and to repair in ju ry . Another possible 
explanation is that bridges connecting dysfunctional podocytes w ith  the 
glom erular capsule activate PECs, in c lud ing  N C A M + progenitor cells, to 
m igrate (Le H ir et ah, 2001). Consistent w ith  the lo w  num ber o f BrdU- 
re ta in ing cells in  the Bowman's capsule of contro l ra t is the presence o f 
m ost PECs expressing the cell cycle in h ib ito r C/EBPS (Barbaro et ah, 2007). 
In  MW F rats, the scanty expression o f C/EBPS in  the Bowm an's capsule 
accounts fo r the h igh p ro life ra tive  rate o f c la u d in l+ PECs. The ro le o f 
C/EBPS in  m ainta in ing the progenitors in  a quiescent state has been 
confirm ed by its m arked constitutive expression in  cu ltu red  N C A M + PECs
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isolated from  capsulated g lom eru li o f contro l rats. That Ang II  decreases 
C/EBP5 expression and m arkedly stim ulates m itosis o f cultured PECs 
h igh lights the a b ility  o f the peptide to enhance PEC activation status 
leading to uncontrolled pro life ra tion.
A ltogether, these find ings indicate tha t in  p ro life ra tive  diseases in  
both humans and rats, cells o f parie ta l o rig in  acquired a pro life ra tive  
phenotype and m igrate towards the glom erular tu ft contribu ting  to the 
form ation o f crescentic lesions. This uncontro lled activation o f renal 
progenitor cells m ay be triggered by the in flam m atory environm ent, 
w h ich characterizes the pro life ra tive  diseases inc lud ing  the crescentic 
glom erulonephritis, and by the consequent release o f mediators from  the 
glom erular tu ft.
In  a search o f m ediators responsible fo r the abnorm al behaviour o f 
progenitor cells in  p ro life ra tive  diseases, we have hypothesized a role fo r 
the SDF-1/CXCR4 pathw ay, due to  its property in  prom oting cell 
m igra tion and p ro life ra tion  (Lapidot et ah, 2005; Ratajczak et ah, 2006). 
Accordingly, evidence is available that the expression o f CXCR4 on cancer 
cells positive ly correlates w ith  the metastatic potentia l o f m u ltip le  tum ors 
(Reckamp et ah, 2008), and that the interaction o f CXCR4 w ith  its ligand 
SDF-1 is the p rinc ipa l effector o f hem atopoietic stem cell m obiliza tion 
from  the bone m arrow  (Lapidot et ah, 2005). In  add ition , CXCR4 receptor 
has been previously found in  CD133+CD24+ progenitor cells isolated from  
norm al hum an kidney (M azzinghi et ah, 2008). Based on these studies, we
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deepen the possible involvem ent o f CXCR4 in  the abnorm al m igra tion  o f 
progenitor cells in  both patients w ith  p ro life ra tive  diseases and in  MW F 
ra t m odel o f progressive nephropathy. In  healthy hum an g lom eru li, on ly 
few  cells in  the Bowm an's capsule are positive fo r CXCR4, whereas in  
p ro life ra tive  disorders the expression o f CXCR4 is m arkedly increased, 
especially in  CD24+ progenitor cells fo rm ing  the crescentic lesions. By 
contrast, the fa in t expression o f CXCR4 in  membranous and diabetic 
nephropathies indicates tha t progenitor cells have little  o r no propensity 
to invade the Bowman's space in  non p ro life ra tive  diseases. A  possible 
explanation of the increased CXCR4 expression exclusively in  p ro life ra tive  
diseases is offered by the in flam m atory nature o f these glom erular 
disorders. In  crescentic glom erulonephritis, im m une com plex localization 
in  the glom erular cap illa ry w a ll and mesangium, induces the recru itm ent 
o f neutroph ils and m onocytes/macrophages to the glom erular tu ft 
(S itprija  et at, 1980; La i et al., 1982). A ctiva ted cells w h ich  in filtra te  the 
glom erulus release soluble cytokines and chemokines tha t enter the 
Bowman's space (S itprija  et at, 1974; Lam bertucci et at, 1988; Indraprasit et 
at, 1985), eventually contribu ting  to  up-regulation o f chemokine receptors 
located on progenitor cells o f the Bowman's capsule (Boucher et at, 1987; 
Ophascharoensuk et at, 1998, Lan et at, 1992). Here, in  patients w ith  
p ro life ra tive  disorders, CD68+ macrophages in filtra tin g  the glom erular 
tu ft (Sanchez-Martin et at, 2011) do no t express SDF-1, w h ich is conversely 
produced by the podocytes activated by the in flam m atory 
m icroenvironm ent (Sayyed et at, 2009). The presence o f SDF-1 provides
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the ligand fo r the receptor CXCR4 w hich is up-regulated on CD133+CD24+ 
parie ta l progenitor cells, u ltim a te ly  prom oting the ir m igra tion and 
pro life ra tion . Consistently, in  MW F rats, the fin d in g  o f a sim ilar 
expression pattern o f CXCR4 in  activated PECs, and o f SDF-1 in  
podocytes, fu rth e r suggests that SDF-1 production by podocytes is 
invo lved in  parie ta l progenitor cell activation leading to crescentic lesion 
form ation.
Besides chemokines, local production o f Ang II, the key peptide o f 
the renin-angiotensin system (RAS), is increased in  p ro te inuric 
glom erulonephritis (K inoshita et at, 2011). Phlogogenic cells can release 
enzymes tha t generate Ang II, inc lud ing  ACE in  monocytes/macrophages 
(Nahm od et at, 2003; Wassmann et at, 2001). The local accum ulation of 
Ang II  activates A T i receptors fu rthe r sustaining the in flam m atory 
environm ent via the production o f reactive oxygen species, cytokines and 
adhesion molecules (Brasier et at, 2002). Since Ang I I  promotes cell 
m igra tion and p ro life ra tion  v ia  A T i receptor (K im  et at, 2011), we sought 
to assess whether renal progenitor cells contribute to the progression of 
hyperplastic lesions as a response to the excessive expression o f this 
receptor on the ir surface. Here, in  patients w ith  p ro life ra tive  disorders, an 
h igh  num ber o f progenitor cells located in  the Bowman's capsule and 
w ith in  the crescentic lesions expresses A T i receptor. By contrast, in  
patients w ith  membranous and diabetic nephropathies, on ly rare cells o f 
the Bowman's capsule demonstrate A T i receptor im m unoreactivity, in  a
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manner s im ila r to norm al hum an glom eru li. Consistently in  M W F rats, the 
m a jo rity  o f cells lin in g  the Bowman's capsule as w e ll as those constitu ting  
the hyperp lastic lesions are h ig h ly  expressive o f the A T i receptor. These 
data suggest a contribu tion o f the Ang II/A T i receptor pathw ay to the 
abnorm al behaviour o f renal progenitors in  p ro life ra tive  diseases. A  
schematic representation show ing the con tribu tion  o f SDF-1/CXCR4 and 
a n g ll/A T l receptor pathways in  crescentic lesion fo rm ation  is given in  
Figure 21.
Another unprecedented resu lt o f the present study is tha t ACE 
in h ib ito r, beside the w e ll-know n effect o f low ering  blood pressure and 
pro te inuria , lim ite d  the form ation o f crescents in  MW F rats w ith  very 
advanced nephropathy, preventing the accum ulation o f extracellu lar 
m atrix and the evolution towards glomerulosclerosis. The reparative 
process induced by ACE in h ib ito r parallels a m arked reduction o f PEC 
and podocyte p ro life ra tion  both in  crescents and in  the Bowman's capsule, 
as demonstrated by restoration o f BrdU  and C/EBP5 expression to  contro l 
levels. Re-establishment o f norm al g lom erular architecture by ACE 
in h ib itio n  associates w ith  reduced activation o f N C A M + progenitors and 
restoration o f the ir d is tribu tion  along the Bowm an's capsule.
A ccord ing ly w ith  find ings in  the ra t m odel, we found a pa tien t 
w ith  extracapillary glom erulonephritis where 8 m onth-treatm ent w ith  the 
ACE in h ib ito r ra m ip ril induces a complete regression of extracapilla ry 
lesions, and possible regeneration o f new cap illa ry tufts. In  both humans
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and rats, the regression o f glom erular hyperplasia fo llo w in g  ACE in h ib ito r 
treatm ent parallels the norm alization o f the up-regulated expression o f the 
A T i receptor on renal progenitor cells, fu rthe r suggesting the involvem ent 
o f A T i receptor expression in  the developm ent o f p ro life ra tive  disorders. 
M oreover, a possible lin k  between A T i receptor and CXCR4 expression 
comes from  the neglig ible CXCR4 expression by progenitor cells in  the 
Bowman's space observed in  the biopsy specimen collected after ACE 
in h ib ito r treatm ent, as w e ll as in  MW F rats treated w ith  lis in o p ril. This 
relationship is fu rthe r supported by find ings tha t RAS in h ib itio n  w ith  
ACE inh ib ito rs  or A T i receptor blockers attenuates CXCR4 m RNA 
expression and pro te in  levels in  the le ft atria in  patients w ith  chronic a tria l 
fib rilla tio n  and m itra l valve disease (Wang et ah, 2009).
A ltogether, in  th is study we demonstrated that in  presence o f an 
extended renal damage in  in flam m atory pro life ra tive  disesases, renal 
progenitor cells lose the ir physiological a b ility  to replace in jured 
podocytes and actively prolife ra te, thus contribu ting  to renal disesase 
progression. These data suggest a possible pathw ay through w h ich the 
ACE in h ib ito r reduces crescentic lesions in  hum an and ra t p ro life ra tive  
renal diseases, and provide a clue fo r designing specific molecules 
targeted to novel players o f renal repair tha t can possibly foster the 
in trins ic  capacity o f the kidney to regenerate.
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Figure 21. A schematic representation o f the pathway involved  
in  crescentic lesion  formation.
In humans and animal model of proliferative diseases, ang II 
(yellow) stimulate visceral podocytes (green) to produce and 
secrete SDF-1. SDF-1 binds its receptor, CXCR4, expressed by a 
subset of PECs (red). In parallel, ang II directly activates ATlr- 
expressing PECs (blue). Both CXCR4 and ATlr promote PEC 
proliferation and migration towards the capillary tuft, leading to 
crescent formation.
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8.1 C o n trib u tio n  to  the thesis by other researchers
Part o f the thesis project was carried on w ith  the collaboration o f 
other researchers o f the Is titu to  d i Ricerche Farmacologiche M ario N egri in  
Bergamo tha t contributed to  the research as fo llow s:
- A n im a l care and treatments were conducted in  collaboration w ith  Dr. 
Fabio SangaUi, Laboratory o f Renal Biophysics, Is titu to  d i Ricerche 
Farmacologiche M ario  N egri. In  particu la r he evaluated prote inuria , 
serum creatinine and systolic blood pressure in  rats, he adm inistered 
lis in o p ril and injected BrdU, and fin a lly  he sacrificed the animals.
- Daniela C avallo tti, U n it o f Advanced M icroscopy, Is titu to  d i Ricerche 
Farmacologiche M ario  N egri, gave me technical assistance fo r sample 
observation w ith  electron m icroscopy.
- D r. C inzia Rota, Laboratory o f C ell B iology and Regenerative M edicine, 
Is titu to  d i Ricerche Farmacologiche M ario  N egri, helped me in  conducting 
in  v itro  experiments.
A ll the other techniques and experiments described in  th is thesis (sample 
preparation and cutting, im m unofluorescence/im m unoperoxidase/ 
im m unogold experiments, in  v itro  experiments, m orphologica l 
evaluations, im m unolabelling quantifications, statistical analysis) were 
perform ed by the PhD student, Paola Rizzo.
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8.2 P ublications concerning the w o rk  described in  th is  thesis
Smeets B, A nge lo tti M L, Rizzo P, D ijkm an H , Lazzeri E, M ooren F, 
B a lle rin i L, Parente E, Sagrinati C, M azzinghi B, Ronconi E, Becherucci F, 
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Renal progenitor cells contribute to  hyperplastic lesions o f 
podocytopathies and crescentic glom erulonephritis. J Am Soc Nephrol 2009 
Dec;20(12):2593-603.
Benigni A*, M o rig i M *, Rizzo P*°, G ag lia rd in i E, Rota C, Abbate M , Ghezzi 
S, Remuzzi A , Remuzzi G. In h ib itin g  angiotensin-converting enzyme 
promotes renal repair by lim itin g  progenitor cell p ro life ra tion  and 
restoring the glom erular architecture. American Journal of Pathology 2011 
Aug;179:628-638. * equally contribu ting  to the w ork, ° correspoding author
Rizzo P*, Perico N *, G agliard in i E, N o ve lli R, A lison MR, Remuzzi G, 
Benigni A . Nature and m ediators o f parie ta l ep ithe lia l cell activation in  
glom erulonephritides o f hum an and rat. American Journal of Pathology 2013 
Dec;183(6):1769-78. * equally contribu ting to the w o rk
8.3 F u ll lis t o f pub lica tions by the candidate on topics no t associated 
w ith  the w o rk  described in  the thesis
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X inaris C, Benedetti V, Rizzo P, Abbate M , Corna D, A zzo lin i N , C onti S, 
Unbekandt M , Davies JA, M o rig i M , Benigni A , Remuzzi G. In  v ivo  
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suspensions. J Am Soc Nephrol 2012 Nov;23(ll):1857-68.
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